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ABSTRACT 
 
It is known that infectious agents elicit different responses in different individuals 
which strengthens the view that susceptibility and resistance to infectious diseases 
has a genetic component. These differences in susceptibility to disease can be 
observed in populations.  APOBEC3G is a member of the cytidine deaminase 
gene family located on chromosome 22. It is crucial in non-permissive cells as it 
functions as part of the innate immunity system and is an inhibitor of the HIV-1 
accessory protein vif. 
 
 The goal of the study was to develop genotyping assays and estimate allele 
frequencies. Thus, genetic variation within APOBEC3G was identified and 
characterized in black South Africans. Indirect genotyping assays were designed 
to amplify regions within the upstream non-coding region, and in exon 4 of the 
coding region of the gene.  Selected polymorphisms were then genotyped using 
allele-specific PCR, RFLP-PCR and Pyrosequencing™ assays.  
 
Reanalysis of sequence data from 2003 showed numerous SNPs were well 
represented. Comparison of sequence data at various SNPs showed that allele 
frequencies were similar to frequencies in other African populations. The only 
sequenced SNP that deviated from the frequencies in Ensembl was -590. Thus the 
sequencing was a useful tool for detection of variation. ASA proved to be the least 
reliable genotyping technique as the minor allele frequency of -571 (0.59) 
deviated from the published frequency of 0.894 in Africans. RFLP analysis 
xi 
 
 
proved more reliable for genotyping -571 and H186R. The minor allele frequency 
was estimated to be 0.84 and 0.32 for -571 and H186R respectively. The 
frequency of H186R is similar to published data from An et al (2004) and Reddy 
et al (2010). If SNPs are in LD they occur together on the same haplotype more 
often than by chance. Usually SNPs that are in LD are in close proximity. 
However our data suggests -571 and H186R SNPs which are 5kb apart are not in 
LD. A LD map of chromosome 22 shows highly variable pattern of LD (Dawson 
et al, 2002). Widespread regions of nearly complete LD up to 804 kb in length are 
intermingled with regions of little or uundetectable LD. Haplotype analysis 
showed the most frequent haplotype was GA. This was the most frequent 
haplotype when the sample types were subdivided according to spoken language. 
in comparison to studies from An et al, (2004) D’ of the two SNPs was estimated 
at 0.967.  The linkage disequilibrium (LD) revealed a non-independence of allele 
segregation because the loci analyzed were strongly linked in the Apobec 3 G 
gene. The data are consistent with greater genetic diversity of African populations 
and can form the basis for further evaluation of the role of variation in this gene in 
response to HIV.  
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Introduction 
 
 1.1   Human Immunodeficiency Virus (HIV) and Acquired Immune 
Deficiency Syndrome (AIDS) in Sub-Saharan Africa 
Human Immunodeficiency Virus (HIV) is transmitted by an exchange of body 
fluids (O’Brien & Nelson, 2004).  The virus affects the immune system.  It kills 
the CD4+ cells, which are critical for the prevention of infections and diseases 
(Barre-Sinoussi et al., 1983).  Consequently, a loss of immunity results, allowing 
organisms that would normally be warded off to cause infections (O’Brien & 
Nelson, 2004).  This is life threatening as it increases susceptibility to infectious 
diseases.  This condition caused by HIV is called Acquired Immune Deficiency 
Syndrome (AIDS) (Barre-Sinoussi et al., 1983).   AIDS is clinically defined when 
the CD4+ T cell count is less than 200cells/mm3 or by being HIV positive and 
having and AIDS-associated illness (UNAIDS/WHO, 2007).   
Statistics reveal that Sub-Saharan Africa has the highest prevalence of HIV 
infections. In this region there were 22.5 million adults living with HIV and 
approximately 1.7 million adults and children had become infected with the virus 
in one year (UNAIDS/WHO, 2007). These alarming statistics are cause for 
concern especially since Southern Africa accounts for one third of all new HIV 
infections and AIDS deaths globally. South Africa is the hardest hit country with 
the largest number of people infected and has the highest HIV prevalence as 
compared to any country (UNAIDS/WHO, 2007). The virus is spreading 
throughout the population and is not limited to high risk groups such as sex-
workers (UNAIDS/WHO, 2005). Women and girls have become especially 
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vulnerable to HIV/AIDS and in 2007 it was estimated that 61 % of adults in South 
Africa living with HIV were women (UNAIDS/WHO, 2007). The key to curbing 
the spread of the virus is to prevent transmission and to implement efficient and 
practical strategies to help those infected with and affected by HIV/AIDS. 
 
1.2     HIV diversity in Africa 
There are two types of HIV; HIV-1 and HIV-2. HIV-1 is further divided into 
groups called Groups M, N, O and P. These groups are further subdivided 
subtypes A-K. HIV-1 group M accounts for more than 95 % of all HIV infection 
around the world apart from HIV-2 infections in certain parts of Africa (Lemey et 
al, 2003). All subtypes of HIV-1 are found in Africa. Subtype B is found mainly 
in Europe, the Americas, Japan and Australia (Heeney et al, 2006).  
The origins of HIV-1 have been very contentious. The first HIV-1 like virus 
called Simian Immunodeficiency Virus (SIVcpz) was characterised in captive 
chimpanzees in 1989. Initially the SIVcpz virus was thought not to be responsible 
for the disease in humans as it could not be determined if wild chimpanzees are 
naturally infected by the virus. Chimpanzees are divided into four subspecies; the 
western, Nigerian, central and eastern chimpanzees (Gagneux et al, 1999). Each 
subspecies occupy a different geographical niche. Sequence analysis of all the 
SIVcpz strains from captive chimpanzees described by Peeters et al (1989) and 
Peeters et al (1992) showed that all these strains clustered together within the 
central chimpanzee subspecies and also formed one cluster within all HIV-1 
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strains. This is indicative of the central subspecies, which encompasses Cameroon 
and the Congo, being the causative agent of HIV-1 virus in humans. 
 
DNA sequencing of archival samples from Zaire (now the Democratic Republic 
of the Congo (DRC)) was used to date the origin of HIV-1 and confirmed the 
evolutionary history (Worobey et al, 2008) as this is the epicentre of diversity. 
The archival samples are designated ZR 59 (a blood plasma sample from 1959) 
and DRC60 (biopsy specimen from female patient in the DRC). The phylogenetic 
analysis demonstrated a short nodal distance between the two. Particularly the 
DRC60 sequence was found to cluster close to the A subtype ancestral node in the 
phylogenetic tree while the ZR59 sequence clustered closer to the subtype D 
(Worobey et al, 2008). This indicates that even 50 years ago group M of HIV-1 
strains had evolved into distinct subtypes that were circulating within the 
populations of this region. The phylogenetic analysis indicates too that there is 
substantial genetic diversity between the two ancestral sequences. This further 
confirms that the virus was present in humans long before the epidemic was 
characterized.  
 
An interesting point has been raised that urbanization has played a vital role in the 
rise of the disease in Africa because the two ancestral sequences cluster with other 
strains from the same region rather than the same subtype, giving rise to viral 
lineages which are more diverse within viral subtypes. Thus it was concluded that 
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the diversification of HIV-1 group M viruses began in Kinshasa (Keele et al, 
2006). 
 
The causative agent of HIV-2 is known to be SIVsm (SIV from Sooty 
Mangabeys). The Sooty Mangabeys naturally are found in the forest of Senegal 
east to Ghana. The origin of HIV-2 has not been so contumacious. A natural 
reservoir of the virus was detected in these monkeys as early as 1989 (Hirsch et 
al, 1989). Unlike HIV-1, each HIV-2 subtype was apparently the result of 
independent cross-species transmission. The most recent common ancestor of 
HIV-2 subtype A was dated to be ~1940 and subtype B 1945 in Guinea-Bissau 
(Lemey et al, 2003). Subtypes A and B are linked to the epidemic in this region 
while other subtypes have been identified in people infected with a single subtype. 
Like HIV-1 transmission of the virus has been marked by a period of 
untraceability followed by an exponential rise in infections. This rise of infections 
is estimated to occur around the same time as the War of Independence between 
1963 and 1974. Once again it is evident that viral epidemics are reliant on socio-
economic conditions.  
 
HIV -1 subtype C is well documented as being the predominant strain in South 
Africa (Rodenberg et al, 2001 & Papathanasopoulos et al, 2002). However there 
is evidence of minor strains such as non-C subtypes and various recombinant 
subtype viruses also being present in South Africa. In addition HIV-1 subtype B is 
4 
 
 
present in the homosexual population (van Harmelen et al, 1997 & Williamson et 
al, 1995). 
1.3   HIV Life Cycle 
The HIV infection begins with HIV adsorption to the CD4 cell via the gp120 
molecules exposed on the surface of the virion. This binding induces a 
conformational change in gp120, another protein of the viral envelope, allowing it 
to bind CCR5 (Doms and Trono, 2000). The conformational change allows gp41 
which becomes exposed to initiate fusion of the viral and host membranes. The 
virus then releases its contents (containing the two RNA strands) into the 
cytoplasmic compartment of the host cell (Figure 1.1). Once in the host cell there 
is a partial uncoating of the capsid to expose the RNA strands. Viral reverse 
transcriptase converts the RNA to DNA, which is a much more stable molecule in 
the cell, and can then recombine with the host’s DNA. The DNA then enters the 
host nucleus where together with viral integrase it is integrated into the host 
genome (Doms and Trono, 2000). Once it is integrated into the host genome it is 
called a provirus. This provirus can remain dormant but become active at any 
stage. If the provirus is active it will express viral proteins for new virions. It uses 
the host cell’s own enzymes to transcribe the double stranded DNA to mRNA. 
Once the viral mRNA is processed in the nucleus, it is transported to the 
cytoplasm where the viruses diverts the host protein  synthesis machinery to 
produce the viral proteins Env(gp160), Gag, Gag-pol, Vif, Vpr, Vpu, Rev, Tat and 
Nef. The initial env protein is processed in the ER and Golgi into the gp120 and 
gp41. The gp120 is glycosylated. The gag and gag-pol polyproteins aggregate 
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near the membrane and interact with plasma membrane and the gp41 present in 
the membrane (Doms and Trono, 2000). As the gag and gag-pol aggregate at the 
plasma membrane the virion begins to form and will be extruded from the host 
cell membrane. As budding occurs the virion takes the host cell lipid layer in 
which the env protein is bound. The virion then undergoes maturation. A virally-
encoded proteinase cleaves the precursor gag, gag-pol into functional proteins. 
 
Figure 1.1   Schematic overview of HIV life cycle. 
 
1.4    Host proteins involved in HIV 
Many approaches have been used to identify host proteins important in HIV 
infection. Classical analysis of host genetics and its involvement in viral genetics 
made use of candidate gene studies, leading to the discovery of numerous AIDS 
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restriction genes that effect susceptibility to viral infection (Hutcheson et al, 
2007). Candidate gene approaches are hypothesis-based. A candidate gene is 
studied for association in order to ascertain any frequency differences between the 
case and control. The advantage of this method is that the study population need 
not be large, though it is often better to have a larger study population to ensure 
accuracy of predictions. The disadvantage of this method lies in the fact that the 
investigator must have some knowledge about the candidate gene or the study 
could be uninformative. Most candidate gene studies have focused on European 
populations (or populations of European origin); little information is available for 
the effects of variation in these genes in African populations where the epidemic 
is expanding at an alarming rate. Nonetheless, a large number of population 
studies have focussed on African Americans. This does not give us a complete 
picture of the disease in Africans due to admixture of genes, but is a good 
platform from which tobase additional studies. 
 
Candidate gene products include chemokine receptors and their variants (CCR5), 
chemokine receptor ligands (SDF), cytokines (IL), the HLA system and various 
factors involved in cellular immunity such as TRIM5α, APOBEC3G and 
3F(Sheehy et al, 2000). 
 
One must study the effects of important genes in Africans to gain the correct and 
comprehensive picture of disease pathogenesis. APOBEC3G is a good candidate 
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for HIV restriction because it allows the expression of an antiviral phenotype in 
non-permissive cells; consequently this innate immune defence is an alternative in 
the design of new therapies. In addition, polymorphisms in the host factors 
characterized in genetic studies are found predominantly in the promoter region or 
regulatory regions. Hence, this region is a good starting point to investigate the 
variation in APOBEC3G and its contribution to HIV/AIDS pathogenesis. In 
addition, numerous variants which modulate HIV pathogenesis have been 
discovered by sequencing the upstream non coding region such as the Duffy 
Antigen Receptor for Chemokines (DARC) (Winkler et al, 2004).  
 
The innate cellular defence system is crucial in detecting and limiting infection 
caused by viruses such as HIV.  Apolipoprotein B mRNA editing enzyme, 
catalytic polypeptide – like 3G (APOBEC3G) is part of this system and was 
discovered via the candidate gene approach. Non-permissive cells which possess 
APOBEC3G allowed for an antiviral phenotype that is overcome by viral protein 
Vif (Sheehy et al, 2000).  
 
1.5    APOBEC 3G 
APOBEC3G is a member of the cytidine deaminase gene family located on 
chromosome 22. It is positioned at 22q13.1- q13.2. It is one of seven genes 
clustered on chromosome 22. The APOBEC3G gene is 10 613 bases in length and 
is transcribed into a protein 384 amino acids long. The protein is homodimeric 
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and is mainly localised within the cytoplasm but small amounts are found within 
the nucleus. As mentioned earlier this protein is an inhibitor of HIV-1 accessory 
protein Vif which will be discussed later. 
 
APOBEC3G has eight exons arranged in tandem (Jarmuz et al, 2002) (Figure 1.2). 
Exons 2, 3, 4 are duplicated within exons 5, 6, 7, respectively. The duplication 
results in the presence of two active sites (exons 2, 5), two linker regions (exons 3, 
6) and two pseudo-catalytic domains (exons 4, 7) (Jarmuz et al, 2002). The active 
site is responsible for target binding and specificity. It contains a zinc-finger motif 
where zinc-binding ligands such as histidine, glutamic acid, proline and cysteine 
are critical for the functioning of the putative deaminase. The two aromatic amino 
acids phenylalanine and tyrosine are responsible for the binding of the target to 
the active site (Jarmuz et al, 2002). Point mutations in the zinc-finger motif 
diminished the activity of APOBEC3G, once again illustrating the importance of 
this domain in establishing an antiviral phenotype in the absence of Vif (Mangeat 
et al, 2003). The pseudo-catalytic domain however lacks the zinc-binding ligands 
and thus has no target binding abilities. It is hypothesized that this domain may 
stabilize the hydrophobic core of the active site in addition it may bind auxiliary 
factors essential for deamination (Jarmuz et al, 2002). 
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Figure 1.2     Schematic representation of exons within APOBEC 3G. The   
                      translated and untranslated portions of the exons are indicated with                         
                       filled and unfilled boxes respectively. The exons encoding the zinc- 
                     coordinating domain are shown as weighted dashed boxes. 
 
1.6    Origin and Evolution of APOBEC Deaminases 
APOBEC1 was the first member of this family to be described. Its crystal 
structure and gene organization were based on E. coli cytidine deaminase. 
Homology modelling revealed that by removing the sequences of nucleotides 
termed the gaps from E. coli cytidine deaminase (ECCDA) the signature sequence 
of APOBEC 1 was derived (Chester et al, 2000). Homology modelling works by 
alignment of the amino acid sequence of the catalytic domains of the ECCDA and 
then APOBEC protein’s amino acid sequence is fitted to these domains (Huthoff 
and Malim, 2005). Other approaches have been used to elucidate the structure and 
evolution of APOBEC proteins. In one instance, DNA and protein sequences of 
all deaminases were pooled from BLAST searches (Conticello et al, 2005). The 
BLAST searches were focused on the deaminases that had the first cluster of the 
active site containing a single zinc ligand. These sequences were then used to 
construct a phylogenetic tree. From these trees the AID/APOBEC family was very 
distinct from other cytidine deaminases as they contained the characteristic zinc 
1 82 4 7 3 65
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coordinating domain. AID/APOBEC1/APOBEC3 was clustered together and has 
diverged from APOBEC 2.  APOBEC2 and AID each had homologs that could be 
traced back to bony fish. However APOBEC1 did not have any non-mammalian 
homologs, suggesting that it was actually derived from AID. In addition, 
APOBEC2 was an ancestral sequence from which the other members of the family 
have diverged (Conticello et al, 2005).  
 
1.6.1    Evolution of the APOBEC3 family 
 It has been proposed that APOBEC3 zinc domains were the result of the 
diversification of two ancestral domains that either constituted a double-domain 
protein or a single domain protein (Conticello et al, 2005). This duplication gave 
rise to seven APOBEC3 genes in humans designated APOBEC3 A, B, C, D, F, G, 
H (Figure 1.3). 
 
Figure 1.3   APOBEC 3 locus position on chromosome 22. 
The sequence which was initially assigned to APOBEC3E was later found to 
encode a second domain of APOBEC3D (Wedekind et al, 2003 & Conticello et 
al, 2005).  This 130kb APOBEC3 cluster is syntenic to the mouse APOBEC 3 
gene found on chromosome 15. However the human APOBEC 3 cluster is much 
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expanded. APOBEC3 homologs are present in primates but absent from bony fish 
and chicken genomes. In addition the sequences flanking the APOBEC3 are 
highly conserved in bony fish and chicken suggesting that the human APOBEC3 
locus may have evolved much later in mammals. This confirms that like 
APOBEC1, APOBEC3 orthologs are restricted to mammals and evolved from 
AID. The duplication and divergence of APOBEC3 locus is thought to occur from 
two ancestral domains termed Z1 and Z2. It is hypothesized that Z1 proteins in 
primates diverged to form single and double domain proteins within the 
APOBEC3 locus. 
1.7     HIV-1 viral infectivity factor (vif) 
HIV-1 encodes a basic 23 kDA protein designated Vif. The protein is translated 
from a singly spliced mRNA and is located in both the cytosol and the nucleus 
(Turner & Summers, 1999). The C-terminal domain is functionally important and 
binds many membranes and is associated with Gag precursors (Khan et al, 2001). 
Deletion of this domain abolishes Vif activity. Comparison of the Vif codon of 
lentiviruses and HIV-1 infected individuals revealed that the Vif is consistently 
conserved (Sova et al, 1995). It is postulated that this limited variability in the 
gene is important in natural HIV-1 infection. 
 
1.8    The Interaction of APOBEC3G and Vif 
In permissive cells infected with Vif defective HIV, APOBEC3G is packaged into 
the virions.  The encapsidated APOBEC3G then deaminates the dC of the minus 
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strand of the cDNA. This converts the cytosine to uracil and the uracil DNA 
glycosylase (UNG) then removes this base (Gu & Sundquist, 2003 & Vartanian et 
al, 2003). The unstable DNA fails to integrate into the host genome to form a 
provirus and it is consequently degraded. If the dU escapes degradation by UNG 
and the mutation becomes incorporated to the HIV genome it will lead to large 
proportion of G to A mutations, which may disrupt the open reading frame 
leading to non-infectious or weakly infectious virions (Gu & Sandquist, 2003 & 
Vartanian et al, 2003). Wild type virus that infects non permissive cells ensures 
that Vif binds to APOBEC3G, and this blocks viral uncoating and thus preventing 
deamination. 
 
In non-permissive cells, Vif has a three-fold action on APOBEC3G. It can bind to 
it and target it for degradation by proteasomes, it can mediate its destruction via 
poly-ubiquitination and it can stop encapsidation of the APOBEC3G into newly 
produced virions in the absence of degradation. The region of APOBEC3G 
implicated in this binding of Vif is the amino terminal (Zhang et al, 2008). The 
process is detailed below. 
 
The most complex function of Vif is its inhibition of APOBEC3G via poly-
ubiquitination which is a proteolytic modification of proteins. The enzymes E1, 
E2, E3 are involved in the covalent conjugation of ubiquitin to a substrate 
consequently ensuring that the protein is degraded by the proteosome. Classically 
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this process is divided into three stages: Activation, Conjugation, and Ligation. 
Initially there is an ATP-dependent activation of ubiquitin by E1. Following this, 
the activated substrate is conjugated to E2 via a thioester bond. E2 acts with E3 to 
transfer the substrate to the target. An iso-peptide bond is formed between the 
terminal lysine of the substrate and the C-terminal glycine of the ubiquitin. The 
target is poly-ubiquinated and is tagged to be degraded by the 26S proteosome. 
This method of ubiquitination is relatively conserved even though all the 
components of the process may not be characterized. 
 
Vif interacts with cellular proteins Cul 5, Elongin B & C and Rbx1 (He et al, 
2008). Vif is probably the F-box protein, which determines target specificity. 
These proteins form SCF-like complex, more specifically, it bears resemblance to 
the VCB-like complex (Figure 1.4). Both of these complexes belong to an E3 
ubiquitin ligase super-family. These complexes are biologically important as they 
selectively bind and ubiquinate specific proteins, targeting them for destruction 
(Yu et al, 2003). They are also vital in regulating and stabilizing signal 
transduction pathways and maintaining the cell cycle. Over-expression of Rbx1 in 
the presence of APOBEC3G decreases infectivity of the virus and Cul 5 inhibits 
ubiquitination of APOBEC3G. Vif interacts with this complex via a conserved 
motif SLQXLA because mutations in this motif drastically reduces the interaction 
between Vif and SCF-like complex (Yu et al, 2003, Mehle et al, 2006). Although 
mutations in this motif reduce interaction with the complex, it does not affect the 
interaction of Vif with APOBEC3G. This is direct evidence that Vif activity alone 
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is not sufficient to overcome the antiviral action of APOBEC3G. However, the 
cellular target of the SCF-like complexes remains elusive. Proteasomes have also 
been implicated in Vif functioning. When a proteosome inhibitor is added to non-
permissive cells Vif fail to exclude APOBEC3G from the resulting progeny and 
the viruses are weakly infectious (Yu et al, 2003). Thus, Vif in conjunction with 
SCF-like complexes and proteosomes are essential in suppressing host antiviral 
phenotype. 
 
Vif is established to interact closely with the components, which are collectively 
termed an E3 ligase. They are said to be an E3 ligase as they have a similar 
structure to the SCF complexes. Rbx1 is an important component of the complex 
and interacted intimately with Cul 5 as seen in mutagenesis studies. Mutants in 
Cul 5 with no Rbx1 binding affect the production of infectious virions in non-
permissive cells (Yu et al, 2003). Vif associates with the E3 ligase by means of a 
conserved SLQ motif (Yu et al, 2003). Mutation in this motif decreases the 
association of Vif with E3 ligase but not with APOBEC3G. Consequently it is 
speculated that Vif interacts with the ligase and simultaneously with APOBEC3G 
acting as a bridge between the two facilitating ubiquitination. The N terminus of 
Vif binds APOBEC3G via its N terminal residues 54 -124. The zinc binding 
domain of Vif has two conserved cysteine that bind Cul5 (Mehle et al, 2006). 
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Figure 1.4    The interaction of Vif and APOBEC3G in non-permissive cells. 
The dimerization domain of Vif is functionally important in blocking the 
incorporation of APOBEC3G into virions (Miller et al, 2007). This “proof of 
concept” was proved by using antagonists against Vif dimerization. This process 
is localized to the SQL motif. The agonists disrupted the expression of Vif in 
addition to the dimerization of Vif (Miller et al, 2007). This disruption facilitated 
the incorporation of APOBEC3G into subsequently produced virions and 
subsequently decreased the HIV infectivity. The regulation of the APOBEC3G by 
Vif is also mediated by functionally important residues such as amino acid 124 to 
127. These are integral to packaging the APOBEC3G into virions while the amino 
acid 128 determines species specificity.  
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1.9   Selection of APOBEC3G and Vif  
The interaction between APOBEC3G and Vif is antagonistic. APOBEC3G is 
under a positive selection pressure to decrease the activity of the Vif, while Vif is 
adapted to enhance the relationship between the two. This antagonistic 
relationship drives the process of evolutionary change. Comparative sequence 
data from non human primates such as Old World monkeys (OWM) New World 
monkeys (NWM) and hominids indicate that APOBEC3G has been under positive 
selection pressure in primates for at least 33 million years (J, Lui et al, 2010 & L, 
Sawyer, 2004).  
 
A characteristic of positive selection is the excess of non-synonymous changes 
(changes which alter the amino acid sequence) over synonymous changes. 
Typically the non-synonymous changes are harmful to the organism and are 
removed from the lineage. However examination of APOBEC3G reveals that non-
synonymous changes are far greater that synonymous changes which is the 
driving force for the fixation of variants with altered proteins (Meyerson and 
Sawyer, 2011). This ultimately affects how the gene variants interact with one 
another.  
 
Interestingly the selection pressure acting on APOBEC3G appears to be ancient 
(Sawyer et al, 2004). APOBEC3G in Old World monkeys and hominids appear to 
have diverged from each other 23 million years ago. The New World monkeys, 
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Old World monkeys and hominids shared a common ancestor 33 million years 
ago. This selection is not limited to a specific domain. It appears that different 
domains within the APOBEC3G proteins have been selected in different primates 
through the years (Sawyer et al, 2004). It is thought that the positive selection of 
APOBEC3G is favored by the changing the charge of the amino acid. This is 
supported by the fact that the Asp 128 is conserved in hominids but Lys 128 in 
conserved in OWM because when the aspartic acid in the human APOBEC3G is 
replaced with the lysine that is found naturally in African Green Monkey protein, 
it becomes resistant to HIV-1 Vif but not SIV Vif (Zhang & Webb, 2004). One 
can infer that the duplication of the primate APOBEC3 locus is in direct response 
to viral infectivity. It may serve as a means for the host to further protect itself 
from infection.  
 
1.10    DNA Polymorphisms 
Innate cellular genes such as APOBEC3G are under tremendous selection pressure 
as indicated previously. The evidence of selection is the variation or 
polymorphisms found within this gene. There are different polymorphisms that 
distinguish individuals within a species (Syvanen, 2001).  Insertions, deletions 
and simple sequence repeats fall into the category of length polymorphisms the 
second category of polymorphism consists of single base changes.  This category 
comprises point mutations and single nucleotide polymorphisms (SNP’s).  The 
most common type of variation within the human genome is the SNP.  They occur 
at one out of every thousand base pairs (Syvanen, 2001) but recent evidence 
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shows that this frequency is much higher (Sabeti et al, 2007).  The consequence of 
detecting and characterizing SNP’s are varied.  SNP is in the regulatory or coding 
region result in synonymous or non-synonymous changes.  Synonymous changes 
so characterized because there is change of nucleotide but not amino acid.  Non-
synonymous changes are classed as being missense, conservative or non-
conservative mutations.  They may also cause the formation of a premature stop 
codon.   
 
1.11    Linkage disequilibrium and haplotypes 
Mendel’s postulates state that there is an independent assortment of genes so that 
each individual/offspring has an equal chance of inheriting either gene of a pair. 
The conclusion is that these genes are in linkage equilibrium. Though, when 
variation at two sites is  inherited together more often than by chance then these 
genes are said to be in linkage disequilibrium (LD) (VanLiere & Rosenberg, 
2008). Often genes and SNPs are inherited as part of a unit with other genes 
which lie close to it. This unit is referred to as a haplotype. LD has an important 
part to play in genetic studies because it can be used to infer the role of SNPs in 
disease. 
 
1.12   Clinical significance of variation within APOBEC3G 
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APOBEC3G variants have a profound influence on the progression to AIDS in a 
study of a cohort of seroconvert, seropositive, seronegative participants of 
European and African American descent (Winkler et al, 2004). Seven SNP were 
identified within the gene. Three were in the putative regulatory region (-571, -
199, -90), one the codon 3 (F119F), one in exon 4 (H186R) and two within the 
introns. This study revealed through haplotype analysis that there are six frequent 
haplotypes which cause these SNPs to be inherited together. Of particular interest 
is the frequency of substitution of histidine to arginine at amino acid position 186 
was higher in African Americans (AA) than European Americans (EA). In 
particular the 186R allele was associated with faster progression to AIDS in the 
African Americans. The frequency was 37 % in AA as compared to 29 % in EA 
(Winkler et al, 2004). However, these observations have not been confirmed in 
other studies. A recent study investigated this polymorphism in Indians. The 186R 
allelic variant could not be found in the study sample and thus no conclusions 
could be drawn about its influence on disease progression in this study population 
(Rathore et al, 2008). There is further evidence that APOBEC3G does not have an 
association with AIDS progression (Do et al, 2005). Genotyping of a French 
cohort which contained subpopulations of seropositive individuals with slow 
progression and fast progression and healthy control subjects failed to show 
significant association of variation in APOBEC3G with disease progression. 
Twenty-nine polymorphisms were identified; these included 14 novel 
polymorphisms all with the exception of one found within the coding region of 
APOBEC3G. Particularly the P-value calculated at non-synonymous change from 
histidine to arginine at position 186 in exon 4 was calculated at 0.69 in pair wise 
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linkage disequilibrium analyses (Do et al, 2005). If there was some significant 
association between the polymorphism and estimated haplotypes then P value 
would be between 0.05 and 0.10. In contrast the P values for the estimated 
haplotypes and the arginine to histidine substitution within the AA seropositive 
sub populations studied was less than 0.024 indicating statistical significance 
(Winkler et al, 2004). However there is some consistency amongst the different 
studies; variation in APOBEC3G showed no association with AIDS progression in 
Europeans.  
 
The distribution of allele frequencies and haplotypes amongst various ethnic 
groups gives an indication as to the importance of population demographics in the 
study of disease progression. It bears testament that ancestry has a strong 
influence on the interaction of populations with viruses. 
 
1.13    Origin of Modern Humans 
The patterns of LD and haplotypes have been used as tools for elucidating the 
genealogical and demographic history of populations. There are two schools of 
thought. The least popular idea is that race or ethnicity can be used to predict 
genetic classification (Tishkoff and Kidd, 2004, Jorde and Wooding, 2004, 
Mountain and Risch; 2004). Historically race has been classified according to 
biological factors such as skin colour, morphology. This in itself is complicated 
and not always correct; traits that produce phenotypic differences are a result of 
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genetic component adapting to the environment in which an individual lives. In 
contrast ethnic races are clustered in groups but this is a consequence of the 
geographic expansion of population out of Africa (Tishkoff & Kidd, 2004). This 
expansion has not given rise to any race specific genes. 
 However the most popular ideology is that LD patterns and population 
haplotypes are useful in determining the geographical distribution and lineage of 
populations (Rosenberg et al, 2002, Lane et al, 2002). These studies show that 
populations that arise from the same geographic region have similar LD patterns 
suggesting that the origins of human populations is important in assessing the 
genetic diversity 
The accepted theory for the origin of modern humans is the Out of Africa theory 
popularly called the Recent Out of Africa theory (ROA) (Cavalli-Sforza et al, 
1992 & Cavalli-Sforza et al, 1997). The theory stipulates that Homo sapiens 
evolved in Africa around 1 million to 2 million years ago (Cavalli-Sforza et al, 
1988 & Cavalli-Sforza et al, 1992 & Cavalli-Sforza, 2006).  The Old World (OW) 
was inhabited by numerous morphologically varied groups of hominids. Evidence 
suggests that in Africa and the Middle East Homo sapiens was present, in Europe 
Homo erectus and Homo neanderthalensis were present. It is argued that by 
roughly 30 000 yrs ago Homo sapiens was dominant in Europe.  
Early human migration can be deciphered using mitochondrial DNA and the Y-
chromosome (Ingman et al, 2003 & Cavalli-Sforza, 2000). Human mitochondrial 
DNA haplotyping shows that all present-day women have inherited mitochondria 
from one woman called Mitochondrial Eve, who lived in Africa 160 000 years 
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ago (Cann et al, 1987 & Vigilant et al, 1991). Similarly Y-chromosomal 
haplotyping confirms that present day men have inherited their Y chromosome 
from a common male ancestor present in Africa 60 00 years ago. 
 
The first exodus out of Africa to Near East occurred some 60 000 years ago 
(Cavalli-Sforza et al, 1988 & Cavalli-Sforza et al, 1992 & Cavalli-Sforza, 2006). 
It is believed that the subsequent migrations to East Asia, Europe & Australia, and 
South Asia occurred 30 000, 40 000 and 50 000 years ago respectively (Wilson & 
Cann, 1992 & Bakewell, Oliver and Haas, 2007). These migrations are confirmed 
by tracing the mitochondrial and Y-chromosome lineages and numerous nuclear 
markers. When genetic and archeologically data are matched with linguistic data 
it seems to support the earlier evidence that the oldest language families are in 
Africa (Cavalli-Sforza, 2006). This mirrors what Charles Darwin postulated over 
a hundred years ago that a genetic tree of evolution will encapsulate the tree of 
linguistics evolution.   
 
Africans have the highest genetic diversity owing to the largest number of 
variable genes and alleles (Jorde et al, 2000 & Tishkoff & Williams, 2002 & 
Cavalli-Sforza et al, 1997 & Jakobson et al, 2008). In comparison, non-African, 
populations do not have high genetic diversity predominantly due to genetic drift, 
which occurred during the migrations of modern humans out of Africa and the 
resulting small populations (Tishkoff & Williams, 2002). In addition, Africans 
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have a lower LD than other populations. The lower LD is indicative of a decrease 
in genetic distance in ‘haplotype blocks’ (Shifman et al, 2003). 
 
1.13.1    Bantu Expansion 
It has been established that the genetic history of Africa is important as it is the 
centre of the evolution of anatomically modern humans. The genetic footprint of 
Africa lies deeply rooted in the migrations of early humans. Human population 
adaptation to viruses shapes the evolution of the genome. That is they are 
provided traces of adaptive evolution in human populations. Therefore detecting 
the association of SNPs in HIV restricting genes can be very valuable in Africans 
because local patterns of LD have been characterized across the genome for Sub-
Saharan South Africans (Donfack et al 2006).  
The Bantu are classified as a group of related individuals who originated in West 
Africa. Bantu, a word meaning “people”, is also used for a collection of related 
languages spoken by these people. The great Bantu Migration started with the 
migration of one group to Cameroon, coastal Congo and inland Kinshasa 
(Diamond et al, 2003, Holden et al, 2001). Later a second wave of migration 
occurred to the east (Diamond et al, 2003, Holden et al, 2001). These Bantu 
occupied regions now known as Uganda. Then groups from Uganda spread farther 
east into Kenya and Tanzania while others continued southward to colonize areas 
that are now the countries Zimbabwe, Botswana, Mozambique, and South Africa 
(Diamond et al, 2003, Holden et al, 2001). As the Bantu migrated so too did their 
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languages. In some regions the language reflects a mixture of Bantu influences 
(Vansina, 1995). These migrations were accompanied by spread of agricultural 
practices. Specifically in South Africa several ethnic groups descended from the 
Nguni and the Tswana-Sotho families within the Bantu Nation (Herbert, 1990 & 
Mitchell & Whitelaw, 2005). These ethnic groups are today known as Zulus, 
Xhosa, Swazi, Ndebele, Basuto, Tswana and Sepedi peoples (Mitchell & 
Whitelaw, 2005). 
 
1.13.2 Genetic substructure of South African populations 
The genetic substructure of seven South African populations, Zulu, Xhosa, 
Tsonga, Sotho, Pedi, Tswana, and Venda, was assessed by studying the Y-
chromosome and the autosomal DNA of these populations (Lane et al, 2002 & 
Mitchell P, 2010). The Y-chromosome is a good indicator of inherited variation 
within and across populations because the Y-chromosome is inherited only by 
males from their fathers. In essence the Y-chromosome gives an indication of how 
males influence the gene pool. The contribution of females and males is assessed 
by the autosomal DNA.  
Black South Africans compromise approximately 77 % of the country’s 
population. In addition, South Africa has 11 official languages. 9 or the 11 official 
languages are Bantu speaking languages. These linguistic groups all belong to the 
Eastern Bantu-speaking group. From Y chromosome data it was shown that the 
languages cluster into 3 specific groups; Tswana/Sotho, Nguni and Venda 
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language groups. The Nguni group comprises the Zulu, Xhosa, Tsonga/Shagaan 
linguistic groups. The Sotho/Tswana group comprises the North Sotho, South 
Sotho and Tswana language groups. 
Measurements of Fst, was very low, indicating these population groups although 
linguistically diverse share more than 98% of their genetic variation, suggesting 
that they all share a common ancestor 
These linguistic groups also show genetic differences between these populations. 
The Nguni linguistic groups split in two with the Zulu and Xhosa forming a 
cluster while the Tsonga and Shangaan form a separate cluster with the Venda. 
The Sotho /Tswana group clusters midway between the two. This is indicative 
that migration events also influence underlying genetic diversity.  
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1.14   Aim 
The aim of the project was to study variation in APOBEC3G in Black South 
Africans in more detail. In 2003 an initial study showed that there is detectable 
variation in the upstream non-coding region of APOBEC3G (Ramdin, 2003). The 
definitive role of APOBEC3G in HIV/AIDS pathogenesis could not be clarified as 
all sequenced study samples were HIV positive and there was no control group 
against which to make a comparison. Further genotyping and sequencing were 
needed to clarify this issue. In addition there was no detection of heterozygotes at 
various SNPs locations within any of the sequenced samples, as sequencing was 
not very reliable. Thus an assay was needed to facilitate rapid heterozygote 
detection and it is vital that this gene be re-examined in detail.  
 
In addition H186R polymorphism was characterised within the study samples. As 
the origin of most South Africans stems from the Bantu expansion 2000 years 
ago, the Bantu-speaking sub-populations found today are still genetically similar 
(Lane et al, 2002). The objectives included the characterization of variation of 
APOBEC3G in black South Africans with particular emphasis on the non-coding 
region. The non-coding region is known to be important in determining the 
functional variant produced as it controls transcription, translation and processing 
events of a gene. Particular attention was paid to SNP -571 as this was found 
within the non-coding region of sequences characterised within Ensembl database 
as well as in the initial sequencing of the samples collected and characterised in 
2003. It was well represented in the 2003 sequences and thus it was decided to 
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further characterise this SNP in a bigger sample size. In addition, the Bantu-
speaking Johannesburg population is representative of the major Bantu-speaking 
ethnic groups in South Africa.  
  
1.15.   Objectives 
1. Re-analyse my Honours sequence data obtained from direct sequencing 
using Sequencher 4.0. 
2. Develop genotyping assays for -571 SNP in the upstream non-coding 
region and H186R in the coding region of APOBEC 3G 
3.  Determine allele and genotype frequencies of the two SNPs. 
4.  Determine linkage disequilibrium of the SNP data and infer haplotypes. 
 
 
 
 
 
 
 
28 
 
 
Chapter 2 
 
 
Materials and Methods  
 
 
2.1     Sample Description 
 
 
Seventy-one samples were collected from HIV positive patients at Johannesburg 
General Hospital (JHB). These samples were used in the initial investigations to 
detect variation within the upstream non coding region of APOBEC3G. In the 
present study 69 of the 71 samples were used for follow-up investigations as 
material was limited. In addition 45 samples were collected from staff and 
students at the University of the Witwatersrand from the Bantu speaking 
population and termed the General Population (GP) (Table 2.1). The HIV status of 
these individuals was unknown.  This set was not used as a control but to ensure 
that a representative panel of variation within the Bantu population was detected 
and not only variation pertaining to HIV positive individuals. Short self-reported 
patient histories of date of first infection, recent CD 4 count, and secondary 
illnesses were obtained from the JHB sample set.  
 
Adding to these 56 samples were received from the HIVNET 028 Study 
(HIVNET). The patients were obtained from five clinic sites in four Southern 
African countries; Malawi, Zimbabwe, Zambia and South Africa. These samples 
included CD4 counts and viral loads; however information on ancestry of 
individuals was not available. In addition, a further set of 91 samples was 
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collected from Helen Joseph Hospital (HJ) (Table 2.1). Short self reported patient 
histories date of first infection, recent CD 4 count, and secondary illnesses were 
also obtained from patients. All samples were collected under informed consent 
(Appendix III).  
 
Table 2.1     Samples collected for the study of variation within APOBEC3G, their    
                    HIV status and the genotyping methods used to detect variation. 
 
 Samples 
HIV Status JHB HIVNET 
 
HJ GP 
HIV positive  71 56 91  
Unknown    45 
Genotyping 
method 
ASA-571 
(69), 
 RFLP-
571(13),  
PYRO-
H186R (13), 
RFLP-H186R 
(32) 
ASA-571 
(56) 
RFLP-H186R 
(38) 
RFLP-571 
(91) 
PYRO-
H186R (91) 
ASA-571 
(40),          
 RFLP-571 
(30),  
 PYRO-
H186R (30), 
RFLP-H186R 
(41) 
 
Data was also collected on geographic origin of participants from JHB, GP and HJ 
study individuals. The participants all filled out a short questionnaire detailing 
information about themselves, their parents and grandparents. This was used to 
ascertain the language affiliation of all participants. Language is a better 
indication of subpopulation affiliation than geographic origin for some parts of 
South Africa, particularly Limpopo Province. Ethics clearance for this study has 
been obtained from the Human Research Ethics Committee by Prof Tracy 
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McLellan.  The clearance number is M040221 (Appendix II). 
 
Within the South African samples it was found that in 57 % there was one 
language present over three generations, 32 % of the recent ancestors were mixed 
with respect to language. In 8.2 % of the sample population the language across 
all three generations was incomplete. 2.9 % of the sample was mixed with respect 
to ethnicity. Within the study populations where there was a single language 
across all three generations, Zulu was the most frequently sampled at 45 %.  At 17 
% the Xhosa ethnicity was second in frequency within this grouping, followed 
closely by Tswana, Sotho, Pedi languages occurring at a frequency of 11 %. The 
Sotho and Pedi languages were present at frequency of 9.2 % and 7.5 % 
respectively within the study sample. The Tsonga, Venda, Ndebele and languages 
represent 4.2 %, 2.5 % and 1.7 % respectively. 
 
2.2     DNA extraction 
 
Genomic DNA extraction was performed using the Qiagen DNA Blood Mini kit 
as per manufacturer’s instructions. This DNA was used to detect variation in 
APOBEC3G. DNA was run on a 1.0 % agarose gel in 1 x TBE at 7V/cm for 75 
min. Gels were stained with 10 µg/ml ethidium bromide (EtBr). Gels were 
visualized under UV light. The DNA concentration in the samples was quantified 
using the Nanodrop ND-1000. DNAs were aliquotted and stored at -20°C.  
 
2.3    Re-analysis of sequence data  
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 Fifteen samples, sequenced in forward and reverse directions in 2003, were 
analysed with Sequencher 4.0 (Gene Codes). Sequences were edited and then 
aligned with each other and a reference sequence from the Human Genome 
Database (NT011520). The sequence alignments appeared as sequence 
chromatograms and allowed detection of discrepancies between and within 
samples representing either SNPs or sequencing errors.  Sequences were visually 
inspected in conjunction with chromatograms and discrepancies were classified as 
SNP according to the following: 
•The peaks were of good height and have little baseline noise. 
•Discrepancies were located in good quality sequence. 
▪Discrepancies were not located within homopolymeric stretches as these cause 
many peaks where one should be. 
 
2.4    Detection of Variation in APOBEC3G 
2.4.1    The genotyping of position -571 using allele specific amplification 
Table 2.4.1   Primer set sequences used in ASA, annealing temperatures, and size    
                     of product sequence. 
Primer Primer Sequence SNP Annealing 
temperature 
Product 
size 
 
-571 G 
PCR 
Reverse 
 
5 ‘CGCCATGGGAACACGCTACCAG 3’ 
5’ TGAAGCCTCACTTCAGGTACC GCTGC 3’ 
 
-
571G 
  
63 C 
 
850 bp 
 
-571 C 
PCR 
Forward 
 
5’GCGCGTCTCACAGCTCCCTTCCCG 3’ 
5’ AGTTCACAGGGGTCACAATGGCT 3’ 
 
-
571C 
 
63.5 C 
 
450 bp 
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Polymerase Chain Reaction (PCR) is a relatively easy method used for amplifying 
DNA. The method is so sensitive that a single DNA molecule can be amplified 
and consequently visualized on an agarose gel as bands.  
 
 The APOBEC 3G was accessed using NCBI and the accession number 
(NT011520) (http://www.ncbi.nlm.nih.gov/gene/60489). To detect variation of 
the -571 SNP Allele Specific Amplification (ASA) was used. ASA was used as an 
alternative to direct sequencing because it is applicable to a large number of 
samples and is therefore inexpensive. In ASA both primers have the identical 
sequence except the base at the 3' end is different for each primer (Okayama et al, 
1989). Each primer will have one alternative for the SNP at the 3' end. 
Homozygotes will only yield PCR product with either primer. Heterozygotes will 
yield a product with both primers (Okayama et al, 1989). 
 
 
The 50 µl reaction mixture for the PCR consisted of 2X Fermentas Master Mix 
(0.05 u/µl Taq DNA polymerase (recombinant), reaction buffer, 4 mM MgCl2, 
0.4 mM of each dNTP (dATP, dCTP, dGTP, and dTTP). Primers (Table 2.4.1) 
were diluted to give a stock concentration of 2 μg/μl (mass (μg) + 0.5 (mass (μg) 
TE) and a working solution of 20 ng/μl (2 μl stock soln + 198 μl water) and 20 – 
100ng of DNA.   
 
The cyclic conditions for the -571G PCR are denaturation at 94 °C for 2 min, 
followed by 35 cycles of denaturation at 94 °C for 30s, annealing temperature at 
63 C for 25 s, extension at 72 °C for 28 s, the final extension is at 72 °C for 5 
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minutes. The cyclic conditions for the -571C PCR are denaturation at 94 °C for 2 
min, followed by 35 cycles of denaturation at 94 °C for 30s, annealing 
temperature at 63.5 C for 25 s, extension at 72 °C for 20 s, the final extension is at 
72 °C for 5 min. PCR products were electrophoresed on a 1% agarose gel stained 
with 10µg/ml EtBr in 1X TBE buffer at 7V/cm for 45 min.   
 
2.4.2    Detection of SNP -571 using Restriction Fragment Length 
Polymorphism (RFLP) 
 
A gradient PCR facilitated the selection of the optimal annealing temperature for 
the amplification of product. Once the gradient PCR established the optimal 
annealing temperature, this temperature was used to amplify the subsequent 
samples using a 50 µl reaction mixture for the PCR consisted of 2X Fermentas 
Master Mix (0.05 u/µl Taq DNA polymerase (recombinant), reaction buffer, 
4 mM MgCl2, 0.4 mM of each dNTP (dATP, dCTP, dGTP, and dTTP). Primers 
were diluted to give a stock concentration of 2 μg/μl (mass (μg) + 0.5 (mass (μg) 
TE) and a working solution of 20 ng/μl (2 μl stock soln + 198 μl water) and 20 – 
100ng of DNA. 
 
The amplicons were then visualized on 1% agarose gel stained with 10µg/ml EtBr 
in 1X TBE buffer at 7V/cm for 1 hour. The amplified samples were then 
subjected to restriction digestion for RFLPs. The restriction digestion was 
optimized by using sequence samples with known nucleotide sequence for GG 
and GC genotypes. The optimization did not include a control for the CC 
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genotype as only one was found by direct sequencing and DNA pertaining to this 
sample was not available.  
 
The RFLP technique was also used to detect variants of SNP -571. The 50µl 
reaction mixture consisted of 10 X Buffer R with BSA, 2.5 U/ μl MvaI 
(Fermentas), 6 μl amplified PCR product and nuclease free water. The digestion 
was carried out for 4 hours at 37 °C. The product was run on a 4% agarose gel 
stained with 10µg/ml EtBr in 1X TBE buffer at 7V/cm for 3 hours at 100V. The 
gels were visualized with the UV transilluminator. The individuals homozygous 
for the C allele will have three bands present at 215 bp, 114bp and 49 bp. Those 
homozygous for the G allele will have 215bp, 163 bp bands present. The 
heterozygotes will have four bands present (215bp, 163bp, 114bp and 49 bp) 
(Figure 2.1). 
 
 
Figure 2.1    Schematic of three genotypes of position -571 of the upstream  
                     non-coding region after digestion by restriction enzyme MvaI. 
 
2.4.3    Genotyping of position 186 in exon 4 of APOBEC3G 
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The Ensembl database showed two SNPs in this exon next to each other (Figure 
2.2); hence conventional genotyping assays such as allele specific PCR or RLFP 
proved to be problematic because of their close proximity. The solution to this 
was to use pyrosequencing to discern the genotypes in the population and to see if 
the SNP upstream of H186R codon changing variant is also found in the Bantu-
speaking South African population (Figure 2.7). 
41101 GCAGCCTGTGTCAGAAAAGAGACGGTCCGCGTGCCACCATGAAGATCATGAATTATGACG 41160 
41161 GTGAGAAGTGGGAGGTTCAGGGGTGTGGGAGAGACTGCTTAAGTGTMTGTGATGGGTCCT 41220 
41221 TCCCACACATACCTGTGGGTCTGCTCTGATGCCTGCAAAGGCCAAGTGTCCCAGGGGAGC 41280 
41281 CTGTGGGGTTGGGTCTGGCGCTGASTGTAACTAGTATCYAGAATATGTCTGGGAGGGGAG 41340 
41341 GGTCCCGAGGTCACAGAAGAGAGGCCAGCTGGGCTTGACTGCKTTCTCTCTTCTTTTTCT 41400  
41401 TAGAATTTCAGCACTGTTGGAGCAAGTTCGTGTACAGCCAAAGAGAGCTATTTGAGCCTT 41460 
41461 GGAATAATCTGCCTAAATATTATATATTACTRCRCATCATGCTGGGGGAGATTCTCAGGT 41520  
41521 GAGGGTCTCCCTCCAGGCTCATCGCCTCGCTCCTCTCACCTCCTGCTCATCCTCTTGAGG 41580 
41581 CCTCCYCTCTGTTCCAGACCAGGTCCTCTCCTGGCCAGGCCCTCCTGCCTTCCCTCCTGC 41640  
41641 CCCCTGCCTGCCCTCGTGGTTACACTCCCTCACCCACACTCCTCGTGCTCCCTCCACCTC 41700  
 
Figure 2.2   Excerpt from Ensembl database: ENST0000026324. Exon 4 is   
                    highlighted in Blue. The codon changing variant of interest is 
                    highlighted in red and yellow and another SNP is found in the 
                    adjacent codon.  
 
 
2.4.3.1    Sequencing of exon 4  
 
The region in exon 4 containing SNP 186 was sequenced by conventional 
sequencing to confirm the exon 4 nucleotide sequence obtained from the Ensembl 
database was correct. A 600bp fragment was amplified by PCR with the following 
primers: Codon 4 fw (AAGCTGCATCGTGACCAGGAGTAT) and Aporev 
(AGAGGAGCGAGGCGATGA). The 40µl reaction mixture for the PCR 
consisted of 2X Fermentas Master Mix (0.05 u/µl Taq DNA polymerase 
(recombinant), reaction buffer, 4 mM MgCl2, 0.4 mM of each dNTP (dATP, 
dCTP, dGTP, and dTTP). Primers were diluted to give a stock concentration of 2 
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μg/μl (mass (μg) + 0.5 (mass (μg) TE) and a working solution of 20 ng/μl (2 μl 
stock soln + 198 μl water) and 20-100ng of DNA. 
 
The cycling conditions for the PCR were denaturation at 94 °C for 2 min, 
followed by 40 cycles of denaturation at 94 °C for 30s, annealing temperature of 
59.6 °C for 30 s, extension at 72 °C for 30 s, the final extension was at 72 °C for 5 
min. PCR products were electrophoresed on 1% agarose gel stained with 10µg/ml 
EtBr in 1X TBE buffer at 7V/cm for 1 hour.  Two samples were sequenced in 
both the forward and reverse directions using sequencing primer ApoSeq1. 
 
2.4.3.2    Detection of variation in exon 4 using pyrosequencing 
 
Pyrosequencing technology is based on a 4-enzyme real-time monitoring of DNA 
by bioluminescence. Essentially there are four reactions that ultimately result in 
the quantitation of a light signal and a sequence of synthesized strand of DNA 
(Ahmadian et al, 2005). For pyrosequencing the sequence surrounding SNPs is 
known and only the dNTP that matches the sequence is added to the reaction and 
it pairs with the sequencing template and an inorganic pyrophosphate is released. 
The tagged amplified fragments serve as the template for the universal primer. 
The released phosphate serves as a template for ATP sulfurylase to produce ATP 
(Figure 2.3). ATP is converted to light by luciferase (Ronaghi, 2008). The 
unincorporated nucleotides and ATP are removed from the reaction by Apyrase 
(Ronaghi et al, 1998). This is crucial in ensuring that the light signal is only the 
result of the correct base being added. The sequence is consolidated as a pyrogram 
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where the peaks give the approximate light signal intensity. The light intensity is 
directly proportional to the sequence of the synthesized DNA (Ronaghi, 2003). 
The software produces a theoretical output of all possible genotypes and the 
pyrograms need to be compared to these to verify the genotypes.  
 
 
Figure 2.3    Schematic overview of pyrosequencing system. When the          
                     correct dNTP is added it pairs with the template and light is  
                     produced. When the dNTP that is added is not complementary  
                     with the template, no light is produced. 
 
The simplicity of the technique allows for high throughput DNA analysis. There 
are many applications of pyrosequencing. This technique was used for genotyping 
SNPs within the coding region of APOBEC3G (Figure 2.7). The primer design is 
very important in the SNP genotyping assay. There are sequence specific primers 
that used to amplify the region of interest. The primers are APOfor   
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38 
 
 
(5’GACGGGGACACCGCTGATCGTTTAGCAAGTTCGTGTACAGCCAAAG
A 3’) and APOrev (AGAGGAGCGAGGCGATGA) and were designed with the 
pyrosequencing software by Dr Zane Lombard from the NHLS. The forward 
primer is tagged at the 5’ end with a sequence: 
 (GACGGGGACACCGCTGATCGTTTA) that matches the biotin labelled 
universal primer (GACGGGGACACCGCTGATCGTTTA). Essentially the 
process is that the forward and reverse primers will amplify the region of 159 bp 
(Figure 2.4). 
 
 
 
 
 
 
 
 
 
Figure 2.4    Position of the primers used for pyrosequencing. 
 
The 50 µl reaction mixture for the PCR consisted of 2X Fermentas Master Mix 
(0.05 u/µl Taq DNA polymerase (recombinant), reaction buffer, 4 mM MgCl2, 
0.4 mM of each dNTP (dATP, dCTP, dGTP, and dTTP). Primers were diluted to 
give a stock concentration of 2 μg/μl (mass (μg) + 0.5 (mass (μg) TE) and a 
working solution of 20 ng/μl (2 μl stock soln + 198 μl water) and 20 – 100ng of 
DNA. 
 
  
 
     Universal Primer 
 
                APOfor                APOrev 
 
 
Template 
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The cycling conditions for the PCR was denaturation at 94 °C for two min, 
followed by 40 cycles of denaturation at 94 °C for 30s, annealing temperature of 
58C for 30 s, extension at 72 °C for 30 s, the final extension was at 72 °C for five 
min. After the successful optimization and amplification of the desired region the 
samples were viewed on a four % agarose gel stained with 10µg/ml EtBr in 1X 
TBE buffer at 7V/cm for three hours at 100V to ensure the correct size and 
minimal primer dimers.  
 
A total volume of 40μl of PCR product was required for each Pyrosequencing™ 
reaction. The PCR products were immobilized to streptavidin sepharose beads in 
the presence of binding buffer (10mM Tris-HCl, 2M NaCl, 1mM EDTA, 1% 
Tween 20), before strand separation was performed by transferring the templates 
between 70% ethanol, denaturation solution (0.2M NaOH) and washing solution 
(10mM Tris-Acetate, pH 7.6). Sequencing primer annealing was then performed 
by heating the templates and primer at 80°C in the presence of annealing buffer 
(20mM Tris-Acetate, 2mM Mg-Acetate) for three minutes.   
 
Because the forward primer was tagged the software assigns the genotype of the 
anti-sense strand. 
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Figure 2.5   Pyrogram of variation at codon positions 185 and 186 in exon 4 of  
                   Apobec 3G 
 
 
2.5    Data Analysis 
2.5.1    Allele and Genotype frequencies 
 
To determine the allele and genotype frequencies of the various SNPs the 
genotypes were counted. The genotype of an individual is defined as its genetic 
makeup with reference to a specific locus. Consequently the genotype frequency 
is the frequency or proportion individuals carrying a certain genotype (Hartl and 
Clark, 1989). The allele frequency on the other hand is the measure of the 
frequency in a population of a specific allele at a given locus for that trait. 
If a locus is bi-allelic (i.e. it has two forms at the locus) then the frequency of the 
three possible genotypes can be represented by f (AA), f (AA), f (AA). If the 
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numbers of individuals (obtained by direct counting of the three genotypes) 
carrying those genotypes is represented by x, y, z respectively. 
 
Genotype frequency of the three genotypes is calculated as follows: 
 F (AA) = x/n where n is the number of individuals present 
f (Aa) = y/n 
f (aa) = z/n 
The allele frequency is determined from the genotype frequency as follows: 
 Let f (A), f (a) represent the alleles frequencies of the A allele and the a allele 
respectively. Then, 
f (A) = (2x+ y)/2n where 2x + y is the number of A alleles 
f (a) = (2z + y)/2n where 2z + y is the number of a alleles 
 
2.5.2     Hardy-Weinberg Equilibrium 
 
The Hardy-Weinberg law predicts genotype frequencies from allele frequencies 
under certain conditions. For a population to be in Hardy-Weinberg equilibrium 
certain conditions have to hold true; there must be random mating, no gene flow 
in or out of the population, the population must be infinitely large and there must 
be equal fertility of all genotypes (Hartl and Clark, 1989). Thus a consequence of 
this model is that allele frequencies will not change from one generation to the 
next. Genotype frequencies can be predicted from allele frequencies.  
 
The model  
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If f (A) = p, 
and f (a) = q, 
then the expected genotypes will be 
 f (AA) = p2 
 f (Aa) = 2 pq 
 f (aa) = q2  
If the population is in equilibrium then, 
p2 + 2pq + q2 = 1 
The statistical Chi-squared test (χ2) is then used to determine if the frequency of 
the expected genotypes is much different from the observed genotypes. 
Χ2 = ∑ (O-E)2 /E  
Where O = observed number of genotypes 
 E = expected number of genotypes 
 
A P value of 0.05 indicates a lack of significant deviation from the Hardy-
Weinberg Model. In this study the estimation of gene frequencies was further 
used to look for differences 
 
2.5.3     Linkage disequilibrium and haplotype analysis 
 
Linkage disequilibrium describes the non-random assortment of alleles at two or 
more loci. It essentially states that some genotypes may occur more or less 
frequently than would be expected if the loci were not linked. Often genes and 
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SNPs are inherited as part of a unit with genes that lie in a close physical 
proximity and this is termed a haplotype. Thus measurements of LD are based on 
comparisons of genotype frequencies of haplotypes. 
 
 
Figure 2.6    Diagrammatic representation of two loci on a gene. There are two    
                    alternative bases for each loci giving rise to four possible haplotypes   
                    during independent assortment of genes. 
 
Linkage disequilibrium was analysed using Linkage Disequilibrium Analyzer 1.0. 
This program implements the EM algorithm (Keyue et al, 2001). To explain LD, 
consider an example. 
Consider two loci each with two alternative alleles on one chromosome 
Haplotype Frequency: 
A1 B1 x11 
A1B2 x12 
A2B1 x21 
A2B2 x22 
 
Then the allele frequency will be: 
Allele Frequency: 
A1 p1 = x11 + x12 
A2 p2 = x21 + x22  
A/C              G/T 
Possible Haplotypes: 
AG 
CT 
AT 
CG 
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B1 q1 = x11 + x21 
B2 q2 = x12 + x22 
 If these alleles are independent then  
x11 = p1q1 
 But if the alleles are not independent and there is a deviation from the observed 
frequencies compared to the expected then it is measured by a parameter D 
(Devlin and Risch, 1995). 
D = x11 - p1q1 
 Allele frequencies can only be between 0 and 1. When either applies then there 
can no D. Therefore the D is normalized by dividing it with the theoretical 
maximum (0.5) of observed allele frequencies (Lewotin, 1964). 
D'= D / Dmax 
 Where D > = 0 or D < 0 
Another important LD measure is r2. This measure informs if alleles at two loci 
are related and is often used to detect loci that influence disease susceptibility 
(VanLiere and Rosenberg, 2008). 
 
Haplotypes analysis was determined using PHASE v 2.1 (Stephens et al, 2001). 
This software implements Bayesian algorithms. One hundred and thirty six 
samples with known genotypes at loci -571 and H186R were used for the 
haplotype analysis. To obtain reliable results the developers suggested that at least 
10 runs were done and inter run variability checked to ensure correct analysis. 
Specifically it was suggested that the Freq output file is checked between runs as 
this will provide the most reliable look at run performance. 
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Figure 2.7  Schematic overview of all methods used on each sample type. 
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Chapter 3 
 
 
Results 
 
3.1    Analysis of upstream non-coding region sequences 
3.1.1    Reanalysis of previously sequenced samples 
 
Fifteen samples were sequenced by Inqaba Biotech in 2003. The samples were 
sequenced in the forward and reverse directions and the average length of the 
sequences was 900bp. In 2003 the forward and reverse sequences of each sample 
were automatically aligned with the putative upstream non-coding region of 
APOBEC 3G (NCBI reference sequence NT_011520.11) to form a contig. Each 
contig was then edited according to the chromatograms. Editing involved 
examining the forward and reverse chromatograms while simultaneously looking 
at the sequences in relation to the reference sequence. Thereafter the reference 
sequence was removed from the contig and a new consensus sequence was 
created from the forward and reverse sequences. The consensus sequence of each 
sample was then aligned automatically to form a new contigs. The relative 
position of the mutations was then noted.  
 
In 2003 sequencing showed that there were numerous point mutations present 
(Figure 3.1).  Different combinations of transitions and transversions were present 
in each sample.  Transversions were the most common point mutations.  Six of the 
eight possible transversions were present in the sequences, T-A, C-A, C-G, T-G, 
G-C, and A-C.  Only three transitions were detected, C-T, A-G, G-A, with C-T 
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being the most frequent transition.  Numerous insertions and deletions were also 
found.  SNPs at -972, -963, -960, -881, were not observed in these samples but 
other new SNP were characterized. During consensus alignment of the samples, 
two sites were of particular interest. At position -590 all sequences were different 
from the reference sequence, there being an A-G transition.  Furthermore, at 
position -571 11 of the 15 sequences were different from the reference sequence 
there being a G-C transversion (Figure 3.1.1.3).  Another SNP (G-C) was found at 
-571 in most of the samples.  One of the previously characterized SNP at -90 was 
also present in some samples. -286 A-G transition was represented in 5 of 10 
sequences.  
  
In 2003 -90 SNP was found at a position of 91 bases upstream of transcription 
initiation. Reanalysis demonstrated after additional editing only 6 from initial 15 
sequences provided informative data. Four heterozygotes (GC) and 2 CC 
homozygotes at position -90 were detected. The allele frequencies could not be 
estimated accurately for this SNP because of the very small sample size. However 
comparative data from Ensembl shows that the allele frequency is relatively the 
same in the Yoruba from Nigeria (G and C allele frequency is 0.562 and 0.438 
respectively) while the frequency of the ancestral allele (C) in Europeans is much 
less than the frequency of the G allele (Table 3.1) 
                
SNPs at position -163, -166 and -199 were not characterized in 2003 but re-
analysis showed them to be well represented in 15 reanalysed samples. Five 
heterozygotes were observed at each position -163, -166 and -199. Heterozygote 
genotypes observed for these positions were found in the same samples. 
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Homozygotes for the ancestral alleles according to the dbSNP database were 
observed at these positions in the remainder of the samples. No homozygote 
genotypes were observed for the minor alleles at each SNP position. The 
remaining 10 samples were homozygous for the major allele at all three loci. 
There is no frequency data available for SNP -163 and -166 for Africans or 
Europeans. However the data available for SNP -199 shows that the frequency of 
the ancestral allele (A) in Africans is similar to the estimated values within the 
study (Table 3.1). 
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Table 3.1 Sequenced data from 2003 and comparative data of other populations 
(http://www.ensembl.org/Homo_sapiens/Variation/Population) 
 
  
NCBI rrs 
ID rs5750743    rs34550797 rs5757463 rs17496004 rs8142124
SNP -90 -163 -166 -199 -571 -590 -881
Alleles C G C A T A A G C G A G C T
A
l
l
e
l
e
 
F
r
e
q
u
e
n
c
y
 
Study 0.667 0.333 0.167 0.833 0.167 0.833 0.167 0.833 0.733 0.267 0 1 0.611 0.389
African 
(Yoruba in 
Ibadan, 
Nigeria,) 0.438 0.562      0.062 0.938 0.894 0.106  0.994 0.006  0713 0.287 
European 
(Utah 
Residents 
(CEPH) with 
Northern and 
Western 
European 
ancestry )  0.318 0.682      0 1 0.900 0.100  0.934 0.066  0.999 0.001 
American 
(Mexican 
Ancestry from 
Los Angeles 
USA)            0.97 0.03  0.970 0.030  0.983  0.017
Asian  
(Han Chinese 
in Bejing, 
China,)           0.913 0.087 1  0  0.997 0.003 
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In subsequent reanalysis, I found that the SNP at -286 was the result of a 
sequencing artifact as may happen when G is preceded by T in direct sequencing.  
 
The SNP at -571 observed during analysis in 2003 was still polymorphic after re-
analysis. Of 15 samples six were heterozygous, eight homozygous for the C allele 
and one was homozygous for the G allele. The frequency of the C allele is 0.733 
and the frequency of the G allele is 0.267 in this group. The population diversity 
on the dbSNP shows that in African populations the allele frequency of the C and 
G alleles to be 0.894 and 0.106 respectively 
(http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5757463.) This 
difference will be discussed later.  
 
Polymorphism at position -881 were not characterized in the 2003 analysis but 
were seen upon re-analysis. Seven heterozygotes and two homozygotes for the 
allele C were observed. However, frequency data could not be ascertained from 
the sequences as the sample size is too small. Frequency data from Ensembl was 
also not available for this SNP. 
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Figure 3.1.          The chromatograms show samples 114, 142 and 131 at SNP positions -163, -166 and -199.  
                            These SNPs appear to be in linkage disequilibrium as they are all either heterozygous at all  
                            positions in sample 114, 142 or homozygous at all position as in sample 131. 
 
 
 
  -163       -166 -199 Position 
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   Figure 3.2    Chromatograms showing -571 and -590 loci (circles). The -571 SNP is well represented in the samples.  
                        The chromatograms show heterozygotes and homozygotes for the alleles. All samples at -590 deviated from  
                        the major allele which is a G. Thus this is an example of a fixed polymorphism. 
Position      -571                                                                                                                   -590 
53 
 
 
3.2 Detection of Variation in APOBEC 3G using Genotyping 
Assays 
 
Genotyping was not possible in all of the samples of each sample set as the DNA 
was not available for all samples at the time of testing. Thus only subset of each 
group was genotyped as indicated in Appendix I. 
 
3.2.1 The genotyping of position -571 using Allele Specific Amplification 
 
Allele-specific PCR was used to genotype the insertion at position -571 in 165 
samples (69 JHB, 56 HIVNET and 40 GP) (Appendix I). Two separate reactions 
were performed; each designed to amplify only one of the possible allelic variants 
at this position. Genotypes were then assigned based on the presence or absence 
of a PCR product following each reaction. Reaction conditions were optimized 
using samples of known genotype (based on the results of direct sequencing) and 
in each case, a control with no sample DNA was included to preclude any false 
positives as a result of DNA contamination. The PCR allowed the SNP to be 
detected in a large sample. The PCR products for each allele of each SNP were 
run together on the same agarose gel to facilitate their correct genotyping (Figure 
3.3).  
Individuals homozygous for a SNP yield a product in one reaction and not the 
other. While heterozygotes yield a product of the same intensity in both reactions. 
The sizes of the products for the different alleles differ allowing accurate 
genotyping. GG homozygotes were more frequent than CC homozygotes. The 
sample population deviated from Hardy-Weinberg equilibrium at a p < 0.05.  
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Figure 3.3   ASA products from -571 SNP were run on a 1 % agarose gel.   
                    Two separate reactions are performed, each resulting in the  
                    amplification of one of the two allelic variants. Genotypes were   
                    resolved based on the presence or absence of a PCR product in  
                    each or both of the reactions. The products of both reactions  
                    were visualized on a 1% agarose gel.  The -571 G reactions  
                    produces a band of size 850bp and the -571 C reaction produces  
                    a band of size 450 bp. Lanes 1-7 are the -571 G reaction of   
                    samples, lane 8 is a GeneRuler™ 100bp Plus DNA Ladder  
                   (Fermentas) and lanes 9-15 are the -571 C reactions of the same  
                   samples. Sample 1 and 3 were not amplified in either reaction.  
                   Samples 2, 4, and 5 are genotyped CC while samples 6 and 7 are  
                   genotyped GC.  
 
 
 3.2.2     Detection of SNP -571 using Restriction Fragment Length 
Polymorphism (RFLP) 
 
A RFLP-PCR assay was designed to genotype the -571 SNP at position within 
APOBEC 3G in 132 samples (13 JHB, 88 HIVNET and 32 GP). The PCR-RFLP 
allowed the SNP to be detected in a large sample size with relative ease. The 
 1   2     3    4     5    6    7      8     9   10   11  12   13   14   15 
900bp 
800bp 
 
450bp
         500bp 
         400bp 
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gradient PCR allowed for the detection of the optimal cyclic conditions to amplify 
the ~400bp region. An annealing temperature of 58°C was chosen as the most 
favourable temperature because two of the three samples amplified to a better 
degree than at annealing temperatures of 59.3°C and 60°C.  
 
The amplified samples were digested with MvaI and fragments run on a 4 % 
agarose gel. Genotypes were assigned based on the restriction profile obtained 
(Figure 3.4).  
 
 
 
 
Figure 3.4   The restriction fragments generated when a 378bp fragment of the 
APOBEC 3G is digested with MvaI. The genotype at this position 
can then be determined by the different restriction profiles 
produced by digestion. The restriction digest was resolved on a 4% 
agarose gel. Lane 1 shows the undigested “no enzyme” control. 
Lanes 2-5 represent homozygotes for the G allele with fragment 
sizes at 215bp and 163bp. Lane 6 is a GeneRulerTM 50bp DNA 
ladder (Fermentas). Lane 7-10 represents heterozygotes with 
fragment sizes at 215bp, 163bp, 114bp and 49bp. The 49bp 
fragments are not clearly visible on the gel.  
 
 
1       2       3       4      5     6      7       8      9       10 
 
300bp 
 
 200bp 
             
              150bp 
 
100bp 
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The assay identified 88 GG homozygotes, 35 heterozygotes and 1 CC 
homozygote. The remaining 12 genotypes were discerned from re-analysis of 
sequence data. Therefore there were in total 95 GG homozygotes, 39 
heterozygotes and 2 CC homozygotes.  The minor allele frequency when 
employing the RFLP-PCR assay was low (0.16) in comparison to the frequency 
found when using the ASA genotyping method. The sample population did not 
deviate from Hardy-Weinberg equilibrium at p<0.5 at RFLP however there is 
deviation from the equilibrium with ASA. 
 
 
3.2.3   Detection of H186R using pyrosequencing 
 
Variation in codon 186 within exon 4 was detected in 132 samples (13 JHB, 88 
HJ, and 32 GP). These were sequenced using pyrosequencing (Figure 3.5). 
  
 
 
 
Figure 3.5   Chromatogram of sample 310 sequence. The highlighted strip                 
                   shows a heterozygote for this sample at position 186. Codon                   
                   185 represented by nucleotides 530, 531 and 532 in the   
                   chromatogram is not heterozygous in this sample. 
 
  t  a   t     t  a  t    a  t   a   t   t   a  c   t   g   c  R   c a   t    c  a  t    g   c  t     g   g  g  g  g     a  g  a  t   t  c   t   c  a 
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The sequencing of a 600bp region of exon 4 confirmed that the sequence from 
Ensembl database was indeed correct (Figure 3.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6    Pyrogram output files for codons 186 and 185. Pyrogram A indicates     
                    the CC genotype at position 186 and 185.Pyrogram B shows TT  
                    genotype was present at 186 in this sample and position 185 was  
                    homozygous for C allele. Pyrogram C shows this sample to be  
                    heterozygous at position 186 and homozygous for the C allele at     
                    position 185. 
 
                                                                    A                          186 C/C        185 C/C 
 
                                                                      B                             186 T/T           185 C/C 
 
 
 
                                                                     C                               186 C/T        185 C/C 
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3.3 Estimation of Gene Frequencies 
3.3.1 Differences at -571 and H186R using various genotyping 
methods 
 
Table 3.3.1     A summary of the genotyping data collected at all polymorphic   
                       positions using allele-specific PCR, RFLP-PCR and     
                       Pyrosequencing™ assays. The genotypes, numbers of individuals  
                       genotyped, genotype and allele frequencies, χ2 and P values are  
                       given for each position. 
 
Genotyping  
Method 
SNP GENOTYPE N ALLEL
E 
MAF GF χ2 
Value 
P-Value 
ASA 
(69 JHB, 56 
HIVNET 
and 40 GP 
sample sets) 
 
-571 
CC 
CG 
GG 
 
46 
44 
75 
165 
C 
G 
0.41 
 
0.279 
0.267 
0.455 
33.70
8 
0.000
1 
RFLP 
 (13 JHB, 
88 HJ  and  
32   GP 
sample sets) 
-571 CC 
CG 
GG 
2 
38 
92 
132 
C 
G 
0.16 
 
0.015 
0.288 
0.697 
0.762 0.683
3 
RFLP 
(32 JHB,38 
HIVNET 
and 41 GP 
sample sets) 
H186R CC 
CT 
TT 
3 
66 
42 
111 
C 
T 
0.32 
 
0.027 
0.594 
0.378 
14.32
6 
0.000
8 
Pyro-
sequencing 
(13 JHB, 88 
HJ  and  
32   GP 
sample sets) 
H186R CC 
CT 
TT 
24 
84 
24 
132 
C 
T 
0.50 
 
0.182 
0.636 
0.182 
9.818 0.007
4 
 
The sample population deviated significantly from Hardy-Weinberg equilibrium 
at – 571 using ASA at a p < 0.05. The GG homozygotes were more frequent than 
the CC homozygote (Table 3.3.1).  The sample population did not deviate from 
Hardy-Weinberg equilibrium at -571 using RFLP at a p >0.05 even though the 
GG homozygotes were more frequent than the CC homozygote. The H186R SNP 
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does deviate from the Hardy-Weinberg Equilibrium using RFLP at p < 0.05. 
There is a large heterozygote excess and almost equal proportion of either 
homozygote. Conversely there is no deviation at this SNP when pyrosequencing is 
used for genotyping. 
 
 
 
3.3.2 Estimation of Pair-wise Allelic Linkage Disequilibrium  
 
Table 3.3.2        Linkage disequilibrium in APOBEC3G gene 
 
Site D D' r2 
-571/ H186R 
(Present Data) 
-0.127 0.216 0.0087 
-571/H186R EA 
(An et al, 2004) 
 1.000  
-571/H186R -AA 
(An et al, 2004) 
 0.967  
 
 
Pair-wise linkage disequilibrium analysis across the two SNPs which are 5030 
base pairs apart on chromosome 22 showed that they are not in linkage 
disequilibrium because the D' value for this association was less than 0.46 (Kidd 
et al, 1988). There is no correlation between the alleles at the two loci because the 
r2 is very low (Table 3.3.2). 
 
Ensembl does not give LD values because allele frequencies are low in European 
populations. However the D' value for African Americans was 0.967 and 1.000 in 
European Americans (An et al, 2004).
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3.3.3 Differences between the Bantu language groups  
 
A comparison of the allele frequencies (Table 3.3.3) was made between the 
different ethnic groups represented in this study. The classification was based on 
the home language spoken by the individual in question and their immediate 
family. The analysis was based on the data from RFLP and pyrosequencing at -
571 and H186R as these were the most reliable genotyping methods tested for 
each SNP. There were a total of 132 samples (Appendix I, Table A 4, A 5 and A 
6) which represent 135 individuals within each genotyping method. However the 
final comparison was conducted using 46 individuals who reported a single 
language spoken by their relatives for three generations, in both their maternal and 
paternal lineages and 40 individuals with uncertain lineages. Zulu speakers 
comprised 40 % of the sample, while five of the ethnic groups (Venda, Tsonga, 
Swazi, Pedi and Ndebele) were represented by fewer than ten individuals and as 
recommended by Lane et al (2008) these groups were pooled for subsequent 
analysis.  
 
The minor allele frequency of the Zulu group at position -571 was lower than that 
of the Xhosa. At position H186R the Xhosa and mixed lineage group showed 
similar frequencies, while the Zulu group had a frequency lower than those of the 
other two groups (Table 3.3.3). The group comprising individuals of mixed or 
unknown lineage had a similar frequency distribution to the Zulu group at -571. 
The Sotho/Tswana group had similar frequencies to that of the Xhosa language 
group. 
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Table 3.3.3        The minor allele frequencies at each of the four polymorphic  
                          sites. Only groups comprising >10 individuals are included. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Group comprising individuals who had parents or grandparents who spoke 
   different languages or who did not know the languages spoken by their relatives. 
 
In Table 3.3.3 group 1 comprised all individuals from all nine ethnic groups with 
complete genotyping data at all four of the polymorphic positions. Group 2 
comprised only individuals who reported Zulu as their home language in three 
generations. Group 3 comprised all individuals who reported Zulu or Xhosa as 
their home language and that of their relatives and group 4 comprised all 
individuals who reported Tswana, Pedi or Sotho as the home language of them 
and their relatives. These groups are classified as macrogroups according to Lane 
et al (2002). 
 
 
 
Language 
Group 
 
 
 
n 
Minor Allele 
Frequency 
 
-571 
 
 
H186R 
 
Zulu 
 
 
34 
 
0.21 
 
0.37 
 
Xhosa 
 
 
12 
 
0.04 
 
0.46 
 
Sotho/ 
Tswana 
 
 
17 
 
0.06 
 
0.47 
 
Other1 
 
 
40 
 
0.20 
 
0.45 
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A comparison of the allele frequencies between the macrogroups (Table 3.3.3) 
revealed minor allele frequencies were similar between groups 2 and 3 at all four 
polymorphic positions. Allele frequencies in group 1 were similar to those in 
groups 2 and 3. 
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Table 3.3.3.1       The genotype (GF) and minor allele frequencies (MAF) at all four polymorphic positions, in the four groups generated by       
                            pooling genotyping data from the nine ethnic groups represented in this study. The numbers individuals genotyped, as                  
                            well as the χ2- and P-values for the χ2 test for goodness-of-fit to Hardy-Weinberg equilibrium are also given 
 
 
SNP 
Position  
 
 
Genotype 
Group 1 Group 2 Group 3 Group 4 
 
n 
 
 
GF 
 
MAF 
χ2 
Value 
P 
Value 
 
n 
 
GF 
 
MAF 
χ2 
Value 
P 
Value 
 
n 
 
GF 
 
MAF 
χ2 
Value 
P 
Value 
 
n 
 
GF 
 
MAF 
χ2 
Value 
P 
Value 
 
-571 
 
 
CC 
CG 
GG 
 
2 
19 
54 
 
0.27 
0.25 
0.72 
 
 
0.15 
 
 
 
0.011 
 
 
0.97 
 
 
2 
10 
22 
 
0.06 
0.29 
0.65 
 
 
0.21 
 
 
0.065 
 
 
0.81 
 
2 
10 
33 
 
0.04 
0.24 
0.72 
 
 
0.16 
 
 
0.02 
 
 
0.89 
       
0 
8 
21 
 
0 
0.28 
0.72 
 
 
0.14 
 
 
0.01 
 
 
0.92 
 
+H186R 
 
 
CC 
CT 
TT 
 
 
10 
44 
21 
 
0.13 
0.59 
0.28 
 
 
0.43 
 
 
0.54 
 
 
0.46 
 
3 
19 
12 
 
0.09 
0.56 
0.35 
 
 
0.37 
 
 
0.19 
 
 
0.66 
 
5 
26 
15 
 
0.11 
0.57 
0.33 
 
 
0.39 
 
 
0.25 
 
 
0.62 
 
5 
18 
6 
 
0.17 
0.62 
0.21 
 
 
0.48 
 
 
0.39 
 
 
0.53 
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3.4 Haplotype Analysis 
 
PHASE 2.1 (Stephens et al., 2001) was used to construct the haplotype structure 
surrounding the two polymorphic sites genotyped and to determine the 
frequencies of these haplotypes in the sample sets JHB, GP and HJ examined by 
RFLP and Pyrosequencing (Table 3.4.1) as well in the four ethnic groups under 
investigation (Table 3.4.2). A total of four possible haplotypes was identified in 
group 1 (which comprised of individuals from all of the nine ethnic groups 
represented) and all these haplotypes were also present in groups 2 and 3. 
However, only three possible haplotypes were identified in the 22 individuals 
comprising group 4.  
 
 Analysis of haplotype frequencies (Table 3.4.1) in the pooled data from samples 
sets JHB, GP and HJ there was a similar frequency between the GG and GA 
haplotypes of 0.419 and 0.413 respectively. The CG and CA haplotypes also 
exhibited a similar frequency. 
 
Analysis of the haplotype frequencies (Table 3.4.2) in each of the groups revealed 
the frequency distributions were similar between groups 1, 2, 3 and 4 of haplotype 
GA and CG. Groups 1, 2 and 3 had similar frequencies of the CA haplotype in 
comparison to group 4. Additionally, while GA was still the most common 
haplotype in this population group, the CG haplotype was the most infrequent 
haplotype amongst all groups within this population. 
 
65 
  
Table 3.4.1  The estimated haplotype frequencies in JHB, GP and HJ sample sets 
                    generated by genotyping data from RFLP and Pyrosequencing     
                    genotyping assays in this study, as calculated using PHASE 2.1.    
                    (Stephens et al., 2001).           
 
 
 
 
 
 
 
 
Table 3.4.2    The estimated haplotype frequencies in each of the four       
                      macrogroups  generated by pooling genotyping data from the nine     
                      ethnic groups represented in this study, as calculated using  
                      PHASE 2.1. (Stephens et al., 2001).           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Haplotype 
 
 
 
Haplotype Frequency 
GG 
 
0.42 
GA 
 
0.41 
CG 
 
0.08 
 
CA 
 
0.09 
 
Haplotype 
 
Haplotype Frequency 
 
Group 1 
 
Group 2 Group 3 Group 4 
GG 
 
0.36 0.29 0.33 0.42 
GA 
 
0.49 0.50 0.50 0.51 
CG 
 
0.07 0.08 0.06 0.06 
CA 
 
0.09 0.13 0.10 <0.01 
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Chapter 4 
4.0. Discussion 
4.1. Direct Sequencing 
The initial goal of the Honours project (Ramdin, 2003) was to find variation 
within the Apobec 3G locus. Once variation was characterised by sequencing 
analysis it was compared to variation within the Ensembl database. Thereafter the 
focus shifted to develop genotyping assays and estimate allele frequencies in the 
SA population as a basis for further work. These were then used to estimate 
haplotypes within all sample sets used. Thereafter as an addition the frequencies 
were estimated based on differences between ethnic groups based on spoken 
language. 
 
In this work the re-analysis of the direct sequencing of the upstream non-coding 
region showed six polymorphisms (--90, 163, -166, -199,-571,-881) in the 15 
samples each sequenced in the forward and reverse directions. Three of these sites 
had previously been identified, while the remaining three were not identified by 
other studies (http://www.ensembl.org/Homo_sapiens/Variation/Population). 
These novel polymorphisms may thus be unique to African populations. This 
supports the observation that Africans have the largest number of population-
specific alleles and that the variation present in non-African populations is largely 
a subset of the variation present in African populations (Armour et al., 1996; 
Tishkoff et al., 1996; Watson et al., 1997; Kidd et al., 1998; Tishkoff et al., 
2000).  
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Six SNPs were identified within the 1000bp region upstream of the non-coding 
region via direct sequencing. SNP -90 was characterised only in six samples. 
SNPs -163, -166 and -199 appeared to be in linkage disequilibrium and well 
represented in most samples. All three sites were either heterozygous or 
homozygous for the major alleles at each position. Both alleles at SNP -571 were 
well represented in the sequenced samples. SNP -881 was only well represented 
in two samples as the sequences were edited on reanalysis and this region at the 
end of the sequence was often eliminated. 
 
 The sequenced polymorphisms were compared to data from Ensembl. The allele 
frequency of -90 SNP in this study is 0.667 of the ancestral allele and 0.333 of the 
G allele. In comparison the frequencies of the African (Yoruba in Ibadan, Nigeria) 
population from Ensembl showed the ancestral allele frequency to be 0.438. The 
G allele is 0.562 
(http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=22:394
72546-39473546;v=rs5750743;vdb=variation;vf=32060683). The discrepancy 
between these two groups is attributed to the detection of specific genotypes. With 
the direct sequencing from 6 sequences 2 CC and 4 CG and no GG genotypes 
were detected. Examining the African population data genotypes CG and GG are 
present in the population with equal frequency of 0.375 the CC genotype occurs at 
a slightly lower frequency of 0.250. In the European (Utah residents with 
Northern and Western European ancestry) population the CG and GG genotypes 
also occur at the same genotype frequency however the numbers of these 
genotypes detected is higher than in the African population 
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(http://www.ensembl.org/Homo_sapiens/Variation/Individual?db=core;r=22:3947
2546-39473546;v=rs5750743;vdb=variation;vf=32060683). Therefore the CC 
genotype is detected at a lower rate in this group. The frequency of minor allele in 
African Americans was 0.319, 0.340 in European Americans in work of An et al 
(2004). Furthermore a very similar minor allele frequency of 0.327 was observed 
in Africans in work of Reddy et al, (2010). These frequencies are very similar to 
the study frequency of 0.333.  
 
Only SNP -199 has been characterised before (rs 34550797). The sequencing data 
indicate very similar frequency of genotypes as in dbSNP. The GG occurred 42 
out of 48 samples in Africans (Yoruba in Ibadan, Nigeria) 
(http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=34550797). In 
addition the GG genotype also occurred in 22 out of 24 samples 
(http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=22:394
72437-39473437;v=rs34550797;vdb=variation;vf=32183674). The allele 
frequency of the G allele is 0.938 and 1.000 in Yoruba and Utah residents 
respectively. In our study the allele frequency is comparable at 0.833 with the 
Yoruba population. The allele frequency of the minor allele is lower in the Yoruba 
population (0.062) than in the study (0.167) 
(http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=22:394
72437-39473437;v=rs34550797;vdb=variation;vf=32183674). Sequencing data 
shows SNP -199 is tightly linked to SNPs -163, -166. They always occur in the 
same samples and if one SNP is heterozygous or homozygous for ancestral allele 
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the other two follow the same pattern. An et al (2004) makes reference to this 
SNP and terms it rare. It was not rare in the sequenced samples though. 
 
 SNP -571 sequencing data frequencies are different from the Ensembl population 
data. The frequency of the minor allele is 0.267 as estimated from the sequencing 
data. In contrast the frequency within Africans is 0.106, 0.100 in Europeans, and 
0.03 and 0.087 in Americans and Asians respectively. The frequencies from the 
study and the Ensembl are vastly different from those of An et al (2004) and 
Reddy et al (2010). The frequencies in these studies are very similar. For Africans 
the frequency is 0.0.91 and 0.089 for African Americans and Africans 
respectively. The European Americans exhibit a frequency of 0.063. 
 
SNPs -590 is a fixed polymorphism in our samples. All the sequenced samples 
deviated from the reference sample at this position. The sequencing data is 
dissimilar from the Ensembl data 
(http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=22:394
71748-39472748;v=rs17496004;vdb=variation;vf=32167980). In fact the 
frequency of the “minor” allele was 1 and the ancestral allele was not present in 
any of the sequenced samples. However the minor allele frequencies of 
Americans (Mexican Ancestry from Los Angeles USA) (0.03) and Europeans 
(Utah Residents (CEPH) with Northern and Western European ancestry) (0.07) 
are comparable to each other. The frequencies of the Yoruba (0.006) and Asians 
(Han Chinese in Bejing, China) (0.000) were also comparable.  
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The minor allele frequency at SNP -881 for Europeans (Iberian population in 
Spain, British in England and Scotland, Finnish in Finland, Toscani in Italia, Utah 
Residents (CEPH) with Northern and Western European ancestry) and Asians 
(Han Chinese in Bejing, China, Japanese in Tokyo, Japan, Southern Han Chinese, 
Chinese Dai in Xishuangbanna, China, Kinh in Ho Chi Minh City, Vietnam) is 
0.001 and 0.003 respectively. In comparison the study data the minor allele 
frequency is 0.389 versus 0.287 for Africans (Yoruba in Ibadan, Nigeria, Luhya in 
Webuye, Kenya, Gambian in Western Divisons in The Gambia, Mende in Sierra 
Leone, Esan in Nigeria, Americans of African Ancestry in SW USA, and African 
Carribbeans in Barbados).  
 
Comparing the sequencing data to Ensembl it is clear that direct sequencing does 
remain the method of choice for detecting variation.  The frequency values 
differed amongst various populations.   It is relatively expensive so in the context 
of this study it was used an exploratory tool. Thereafter, indirect genotyping 
assays were designed to genotype the study population.   
 
4.2. Genotyping of -571 and H186R SNP 
 
Allele specific amplification did allow the genotyping of some samples of study 
population at -571. 
 
However, in this study the results of ASA differed from the RFLP analysis, as the 
population deviated from Hardy Weinberg equilibrium. In addition the minor 
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allele frequency is 0.59 and it deviates from the sequencing (0.267) and Ensembl 
data in Africans (0.106), Europeans (0.100), Americans (0.03), and Asians 
(0.087). In ASA homozygotes were represented by a single band in either reaction 
while heterozygotes are represented by two bands of equal intensity. Certain 
samples amplified with two bands but of very unequal intensity, a very bright 
band and a very dim band. Thus one has to use discretion when genotyping these 
samples by this method. The deviation from Hardy Weinberg is the result of the 
incorrect genotyping, which is the result of the assay not being specific enough to 
detect the variants correctly.  
 
A great deal of time and effort has been devoted to the characterization and 
genotyping of SNPs but genotyping errors are not uncommon in population 
studies (Hosking et al, 2004). These can occur at any step of the genotyping 
process from sampling through to the actual procedure. While all efforts are made 
to eliminate errors it is important to characterise and quantify this error. This 
estimation become increasing important if populations of unrelated individuals 
(such as here) are genotyped because one cannot use Mendelian inheritance to 
check inconsistencies as in family studies. It has been shown that the source of the 
genotyping error can also be dependent on the method used to evaluate the SNP as 
is the case in this study where ASA revealed incorrect genotypes while RFLP 
analysis was reproducible and more reliable in genotyping (Hosking et al, 2004). 
While HWE is a good measure to identify genotyping errors it is important to note 
that this too is also dependant on the minor allele frequency of the SNP under 
investigation and the number of samples analysed. It has been documented that in 
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SNPs heterozygotes may be problematic as they may lead to a phenomenon of 
allelic dropout (Cutler, 2001). Commonly two reactions are used to genotype each 
locus and allelic dropout occurs when one of the reactions fails; this is interpreted 
as a homozygote even though in reality the individual is heterozygous at that 
locus. This can account for the increase in GG genotype of -571 when using ASA 
and subsequent deviation from HWE. In ASA the success of this technique is also 
heavily dependent on the decreased ability of Taq DNA polymerase to extend 
mismatched bases at the 3' end of an oligonucleotide primer (Newton et al., 1989; 
Wu et al., 1989; Sarkar et al., 1990; Huang et al., 1992; Ayyadevara et al., 2000) 
due to its lack of 3' to 5' exonuclease activity (Tindall and Kunkel, 1988). 
However, the ability of Taq polymerase to extend mismatches is not decreased to 
the same extent for all base pairs, as the resulting changes in the thermodynamic 
parameters that govern these reactions are different for each of the mismatched 
pairs (Newton et al., 1989; Kwok et al., 1990; Huang et al., 1992; Ayyadevara et 
al., 2000). The complexity of this situation is further compounded by the 
influence of the base immediately 5' to the mismatch on these same 
thermodynamic parameters (Breslauer et al., 1986; Mendelman et al., 1989; 
SantaLucia et al., 1996). Thus it seems that the initial starting point of any study 
should be to determine the real error by an initial pilot study on a subset of 
samples which was not done in this study.  
 
The RFLP analysis was a more reliable technique. The discriminatory power is 
great because it allows one to design the assay at a population level as in our 
study. The uncut control in the RFLP analysis ensured the assay was working 
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correctly. In addition, the sequence data allowed the assay to be tested with 
control samples where the genotype was known. The drawback of using this 
technique is that a large amount DNA is required. This can be overcome by an 
initial PCR amplification as in this study. Genotyping by RFLP analysis the study 
population did not deviate from the HWE. However SNP -571 minor allele 
frequency (0.84) is dissimilar from sequencing data (0.267) and Africans (Yoruba, 
Nigeria) (0.106). In this instance it seems that RFLP technique was not reliable in 
detecting the variation in-571. However it proved very reliable when detecting 
variation in H186R. The minor allele frequency of the study population was 0.32. 
This is similar to the frequency of African Americans from the work An et al and 
Africans in Reddy et al (2010) where the frequencies were 0.368 and 0.307 
respectively. 
  
 
 Similarly, pyrosequencing is a reliable technique because it is based on 
sequencing. However, it does require a lot of technical work to get the assay 
working. Once the assay is optimized a large number of samples can be genotyped 
at once. On the other hand genotyping as the frequency in H186R of the minor 
allele (0.50) is different from published literature.   
 
4.3. Genetic variation in South Africans 
 
It is necessary to have an understanding of the local demographic history which 
has helped to outline patterns of genetic variation at this locus (Tishkoff and  
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Verrelli, 2003). This is necessary because if population substructure is present, it 
is possible to detect false associations between random markers with no physical 
linkage to susceptibility loci and a disease phenotype (Pritchard and Rosenberg, 
1999). 
 
The Zulu and Xhosa ethnic groups showed differences in allele frequency to each 
other and the group comprising individuals of mixed or unknown ancestry at 
polymorphic positions. The ethnic groups showed differences in allele frequency 
to each other and the group comprising individuals of mixed or unknown ancestry 
at all polymorphic positions. This supports the findings of Lane et al. (2002), that 
the black South African population does show distinct differences among the 
representative ethnic groups. However while Lane et al. (2002) found the Zulu 
and Xhosa shared similar patterns of variation, the allele frequency distribution 
between these two groups in this study differed at all polymorphic positions. This 
inconsistency may however, simply is a consequence of the relatively small 
sample sizes available for study in this investigation. 
 
The samples were representative of the population (Zulu speakers, Xhosa, 
Tswana, Sotho, Pedi, Tsonga, Venda, and Ndebele); some samples had to be 
pooled as suggested by Lane et al (2002) for subsequent analysis as they would be 
uninformative if not grouped.  
 
Macrogroup 1 comprised speakers from all 9 ethnic groups, macrogroup 2 
constituted Zulu speakers, macrogroup 3 consisted of Zulu and Xhosa Speakers 
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while macrogroup 4 encompassed Sotho, Tswana and Pedi speakers. A 
comparison of allele frequencies showed that group 1 had similar frequencies to 
that of macrogroups 2 and 3. This is not surprising that considering that Zulu and 
Xhosa speakers comprised 45 % of the population. Macrogroup 2 had similar 
frequencies to group 3, consistent with the findings by Lane et al (2002) that Zulu 
and Xhosa speakers have similar patterns of variations as they are linguistically 
similar. However group 4 had different allele frequencies in comparison to 
macrogroups 2 and 3. This is once again consistent with the findings of Lane et al 
(2002) that Sotho/Tswana speakers have different patterns of variation from Zulu 
and Xhosa speakers and are in fact linguistically diverse.  
 
There is strong evidence for population substructure at the polymorphic loci 
across the macrogroups. If one compares the allele frequency of groups, group 1 
has the same frequency as the average of macrogroups 3 and 4. This confirms that 
group 3 and 4 are subpopulations of group 1. 
 
I did not find evidence of the Wahlund effect, which is the reduction of 
heterozygosity in pooled populations by comparison of genotype frequencies 
(Hartl and Clark, 1989). This effect is also indicative of population substructure 
and may also account for the pooled sample deviating from HWE, which is not 
the case in this study. However it is important to note that if there is no 
noteworthy difference of allele frequencies between the different groups, the 
heterozygosity reduction will not be sufficient to cause a deviation from HWE. 
This is consistent with the findings in this study that shows that the macrogroups 
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did deviate from HWE even though there is some evidence of population 
substructure at the loci explained earlier. 
In addition LD also plays a pivotal role in population substructure. Africans have 
the highest genetic diversity owing to the largest number of variable genes and 
alleles (Jorder et al, 2000 & Tishkoff & Williams, 2002 & Cavalli-Sforza et al, 
1997 & Jakobson et al, 2008). In comparison non-African populations do not have 
high genetic diversity predominantly due to genetic drift, which occurred during 
the migration of modern humans out of Africa and resulted in a small population 
(Tishkoff & Williams, 2002). Thus LD extends over shorter distances in Africans 
versus Non-Africans and that distance is estimated to be approximately 3-10kb 
(Reich et al., 2001). However studies within the population’s genetics laboratory 
reveal that this LD acts over an even shorter distance in African populations 
(Heitkamp et al, personal communication).   
The pairwise allelic Linkage Disequilibrium of -571 and H186R showed that they 
are not in Linkage Disequilibrium, |D'| is 0.216. In contrast they appear to be 
linked in AA and the |D'| is 0.967 and 1.000 in EA (An et al, 2004). This lack of 
correlation is surprising as the SNPs are just over 5000bp apart. Thus should be in 
strong linkage equilibrium as suggested by the literature and our own laboratory 
estimates. However this shows that LD is strongly affect by population history, 
selection, and sample size. The sample size may not have been sufficient to detect 
the LD. In addition another compounding reason may be the selection of study 
participants. These participants were all matched for ethnicity but not other 
parameters which may have underlying effects on the LD. As mentioned 
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previously both D’ and r2 are measures used to quantify LD. However their 
interpretation is different. It is thought that while both ranges from 0 to 1, r2 are 
the more accurate measure. This is so because there is an inverse relationship 
between r2 and sample size. While the calculated r2 value is small it is not 
dependant on the sample size. Importantly because genes are linked on the same 
chromosome does not mean they will be in linkage disequilibrium. It is known 
that intermediate values of D’ from ~0.3 to 0.7 is difficult to interpret as the D’ 
value can be highly variable in pairs of sites that are separated by large distance 
(Wall & Pritchard, 2003). 
 
Haplotype analysis revealed four haplotypes between the SNPs within the whole 
population and when the population was grouped according to different 
languages. GA was the most common while CG was the most infrequent amongst 
all macrogroups. These differences in haplotype frequency, however small, reflect 
both the low levels of LD between the different pairs of polymorphisms and the 
differences in the allele frequencies observed between the groups. These results 
thus concur with those based on the analysis of genotype and allele frequencies 
and support the view that population substructure exists within the black South 
African population. 
 
APOBEC3G remains a promising target in the study of HIV/AIDS pathogenesis. 
Functional studies need to be conducted to ascertain the exact contribution of this 
gene product in HIV/AIDS. Future studies should include expression analysis on 
well characterised samples. A good example of expression analysis to use in 
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future studies is siRNA analysis directed against APOBEC3G. This will show the 
efficiency of APOBEC3G proteins on retroviral infection in a South African 
context where HIV-1 type C is the most prevalent subtype. To determine with 
accuracy if this gene is involved in susceptibility to HIV and progression to AIDS 
well characterised subjects need to be followed over time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79 
  
References 
 
Ahmadian, A., Ehn, M., Hober, S. 2006. Pyrosequencing: History, biochemistry, 
future. Clinica Chimica Acta 363: 83-94. 
 
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, 
P. M., Berger, E. A. 1996. CC CKR5: A RANTES, MIP- 1aplha, MIP- 1beta β 
receptor as a fusion co factor for the macrophage-trophic HIV. Science 272: 1955-
58. 
 
An, P., Bleiber, G., Duggal, P., Nelson, G., May, M. Mangeat, B., Alobwede, I., 
Trono, D., Vlahov, D., Donfield, S., Goedert, J. J., Phair, J., Buchbinder, S., 
O'Brien, S. J., Telenti, A., Winkler, C. A. 2004.  APOBEC3G Genetic Variants 
and Their Influence on the Progression to AIDS. Journal of Virology 78: 11070- 
11076. 
 
Armour, J. A. L., Anttinen, T., May, C. A., Vega, E. E., Sajantila, A., Kidd, J. R., 
Kidd, K. K., Bertranpetit, J., Pääbo, S., Jeffreys, A. J. 1996. Minisatellite diversity 
supports a recent African origin for modern humans. Nature Genetics 13: 154-
160. 
Ayyadevara, S., Thaden, J. J. and Reis, R. J. 2000. Discrimination of primer 3’-
nucleotide mismatch by Taq DNA polymerase during polymerase chain reaction. 
Analytical Biochemistry 284: 11-18. 
 
 
80 
  
Bakewell, Oliver and Hein de Haas (2007) African Migrations: continuities, 
discontinuities and recent transformations. in Patrick Chabal, Ulf Engel and Leo 
de Haan (eds.) African Alternatives. Leiden: Brill: 95-118. 
 
Bailey, J. R., Zhang, H., Wegweiser, B. W., Yang, H., Herrera, L., Ahonkhai, A., 
Williams, T. M., Siliciano, R. F., Blankson, J. N. 2007. Evolution of HIV-1 in a 
HLA-B*57-positive patient during virologic escape. Journal of Infectious Disease 
196: 50-55. 
 
Barre-Sinoussi, F., Chemann, J.C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest 
, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., 
Montagnier, L. 1983. Isolation of a T-lymphotropic retrovirus from a patient at 
risk for acquired immune deficiency syndrome (AIDS). Science 220: 868-871. 
 
Berglund, J., Pollard, K. S., Webster, M. T. 2009. Hotspots of biased nucleotide 
substitutions in human genes. PLoS Biology 7: e1000026. 
 
Brumme, Z. A., Brumme, C. J., Heckerman, D., Korber, B. T., Daniels, M., 
Carlson, J., Kadie, C., Bhattacharya, T., Chui, C., Szinger, J., Mo, T., Hogg, R. S., 
Montaner, J. S., Frahm, N., Brander, C., Walker, B. D., Harrigan, P. R. 2007. 
Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and 
Accessory/Regulatory Genes of HIV-1. PLoS Pathogens 3: e94. 
 
81 
  
Cann, R. L., Stoneking, M., Wilson, A. C. 1987. Mitochondrial DNA and human 
evolution. Nature 325: 31-36. 
 
Carrington, M., Nelson, G., O'Brien, S. J., 2001.Considering genetic profiles in 
functional studies of immune responsiveness to HIV-1. Immunology Letters 79: 
131-140. 
 
Cavalli-Sforza, L. L. 1997. Genes, people and languages. Proceedings of the 
National Academy of Sciences 94: 7719-7724. 
 
Cavalli-Sforza, L. L., Minch, E., Mountain, J.L. 1992. Co evolution of genes and 
languages revisited. Proceedings of the National Academy of Sciences 89: 5260-
5264. 
 
Charron, D. 2005. Immunogenetics today: HLA, MHC and much more. Current 
Opinion in Immunology 17: 493-497. 
 
Chester, A., Scott, J., Anant, S., Navaratnam, N. 2000.  RNA editing: cytidine to      
     uridine conversion in apolipoprotein B mRNA. Biochimica et Biophysica Acta  
    1494: 1-13. 
 
Clapham, P.R, McKnight, A. 2001. HIV-1 receptors and cell tropism. British 
Medical Bulletin 58: 43-59. 
 
82 
  
Conticello, S. G., Thomas, C. J. F., Petersen-Mahrt, S. K., Neuberger, M. S. 2005. 
Evolution of the AID/APOBEC family of polynucleotide (deoxy) cytidine 
deaminases. Molecular Biology and Evolution 22: 367-377. 
 
Devlin, B., Risch, N.1995. A comparison of Linkage Disequilibrium measure for 
fine scale mapping. Genomics 29: 311-322. 
 
Diamond, J., and Bellawood, P. 2003. Farmers and Their Languages: The First 
Expansions. Science 300: 597-603. 
 
Do, H., Vasilescu, A., Diop, G., Hirtzig, T., Heath, S., Coulonges, C., Rappaport,  
J., Therwath, A., Lathrop, M., Matsuda, F., Zagury, J. F. 2005. Exhaustive 
genotyping of the CEM15 (APOBEC3G) gene and the absence of association 
with AIDS progression in a French cohort. The Journal of Infectious Disease 191: 
159-163. 
 
Doms, R. W., Trono, D. 2000. The plasma membrane as a combat zone in the 
HIV battlefield. Genes and Development 14: 2677-2688. 
 
Donfack, J., Buchinsky, F. J., Post C., Ehrlich, G. D. 2006. Human susceptibility 
to viral infection: The search for HIV protective alleles among Africans by means 
of genome-wide studies. AIDS Research and Human Retroviruses 22: 925-930. 
 
 
83 
  
Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale M, Zhang, 
K., Gumbs, C., Castagna, A., Cossarizza, A., Cozzi-Lepri, A., De Luca, A., 
Easterbrook, P., Francioli, P., Mallal, S., Martinez-Picado, J., Miro, J. M., Obel, 
N., Smith, J. P., Wyniger, J., Descombes, P., Antonarakis, S. E., Letvin, N. L., 
McMichael, A. J., Haynes, B. F., Telenti, A., Goldstein, D. B. 2007. A whole 
genome association of major determinants for host control of HIV-1. Science 317: 
944-947. 
Galtier, N., Duret, L., Glemin, S., Ranwez, V. 2009. GC-biased gene conversion 
promotes the fixation of deleterious amino acid changes in primates. Trends in 
Genetics 25: e1-5. 
 
Goldstein, D. B., Weale, M. E. 2001. Population genomics: linkage disequilibrium 
holds the key. Current Biology 24: R576-R579. 
 
Gu, Y., Sundquist, W. L. 2003. Good to CU. Nature 424: 21-22. 
 
Hartl, D. L. and Clark, A. G. 1989. Principles of population genetics, 2nd edition. 
Sinauer Associates Inc., Sunderland, Massachusetts. pp 282-288. 
 
He, Z., Zhang, W., Chen, G., Xu, R., Yu, X. F. 2008. Characterization of 
conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F 
interaction. Journal of Molecular Biology 381: 1000-1011. 
 
84 
  
Hedrick, P. W., Verrelli, B. C. 2006. ‘Ground truth’ for the selection on CCR5-
∆32. Trends in Genetics 22: 293-296. 
 
Heeney, J. L., Dalgeish, A. G., Weiss, R. A. 2006. Origins of HIV and the 
evolution of resistance to AIDS. Science 313: 462-466. 
 
Herbert, R. K. 1990. The Sociohistory of clicks in Southern Bantu. 
Anthropological Linguistics 32: 295-303. 
 
Hirsch, V., Olmsted, R. A., Murphey-Corb, M., Purcell, R. H., Johnson, P., R. 
1989. An African primate SIVsm closely related to HIV-2. Nature 339: 389-392. 
 
Holden, C. J. 2001. Bantu language trees reflect the spread of farming across sub-
Saharan Africa: a maximum-parsimony analysis. The Royal Society 269: 793-799. 
 
Hosking, L., Lumsden, S., Lewis, K., Yeo, A., McCarthy, L., Bansal, A., Riley, J., 
Purvis, I., Xu, C. F. 2004. Detection of genotyping errors by Hardy-Weinberg 
equilibrium testing. European Journal of Human Genetics 12: 395-399. 
 
Huang, M., Arnheim, N., Goodman, M.F. 1992. Extension of base mispairs by 
Taq DNA polymerase: implications for single nucleotide discrimination in PCR. 
Nucleic Acids Research 20: 4567-4573. 
85 
  
Hudson, R. R. The sampling distribution of linkage disequilibrium under an 
infinite allele model without selection. Genetics 109, 611–631 (1985). 
 
Hutcheson, H. B., Lautenberger, J. A., Nelson, G. W., Pontius,J. U., Kessing, B. 
D., Winkler, C. A., Smith, M. W., Johnson, R., Stephens, R., Phair, J., Goedert,  J. 
J., Donfield, S., O'Brien, S. J. 2008. Detecting AIDS restriction genes: From 
candidate genes to genome-wide association discovery. Vaccine 26: 2951-2965. 
 
Huthoff, H., Malim, M. H. 2005. Cytidine deamination and resistance to retroviral 
infection: towards a structural understanding of the APOBEC proteins. Virology 
334: 147-153. 
Ingman, M., and Gyllensten, U. 2003. Mitochondrial genome variation and 
evolutionary history of Australian and New Guinean aborigines. Genome Res. 13: 
1600-6. 
 
Jakobsson, M., Scholz, S. W., Scheet, P., Raphael Gibbs, J., VanLiere, J. M., 
Fung, H.C., Szpiech, Z. A., Degnan, J. H., Wang, K., Guerreiro, R., Bras, J. M., 
Schymick, J. C., Hernandez, D. G., Traynor, B. J., Simon-Sanchez, J., Matarin,  
M., Britton, A., van de Leemput, J., Rafferty, I., Bucan, M., Cann, H. M., Hardy,  
J. A., Rosenberg, N. A., Singleton, A. B. 2008. Genotype, haplotype and copy-
number variation in worldwide human populations. Nature 451: 998-1003. 
 
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., 
Navaratnam, N. 2002. An anthropoid specific locus of orphan C to U RNA editing 
enzymes on Chromosome 22. Genomics 79: 285-296. 
86 
  
 
Jorde, L. B., Watkins, W. S., Bamshad, M. J., Dixon, M. E., Ricker, C. E. 2000. 
The distribution of human genetic diversity: a comparison of mitochondrial, 
autosomal, and Y chromosome data, American Journal of Human Genetics 66: 
979–988. 
 
Keele, B. F., Van Herverswyn, F., Li, Y., Bailes, E., Takehisa, J., Santiago, M. L., 
Bibollet-Ruche, F., Chen, Y., Wain, L. V., Liegeois, F., Loul, S., Ngole, E. M., 
Bienvenue, Y., Delaporte, E., Brookfield, J. F., Sharp, P. M., Shaw, G. M., 
Peeters, M., Hahn, B. H. 2006. Chimpanzees reservoirs of pandemic and 
nonpandemic HIV-1. Science 313: 523-526. 
 
Keyue, D., Zhou, K., He, F., Shen, Y. 2003. LDA – A java-based linkage. 
Bioinformatics 19: 2147- 2148. 
 
Khan, M., Garcia-Barro, M., Powell, M. 2001. Restoration of wild-type infectivity 
to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse 
transcription. Journal of Virology 24: 12081-12087. 
 
Kidd, K. K., Morar, B., Castiglione, C. M., Zhao, H., Pakistis, A. J., Speed, W. C., 
Bonne-Tamir, B., Lu, R. B., Goldman, D., Lee, C., Nam, Y. S., Grandy, D. K., 
Jenkins, T., Kidd, J. R. 1998. A global survey of haplotype frequencies and 
linkage disequilibrium at the DRD2 locus. Human Genetics 103: 211-227.  
 
87 
  
Klenerman, P., Wu, Y., Phillips, R. 2002. HIV: current opinion in escapology. 
Current Opinion in Microbiology 5: 408-413. 
 
Klitz, W., Brautbar, C., Schito, A. M., Barcellos, L. F., Oksenberg, J. R. 2001. 
Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish 
and Northern European population samples. Human Immunology 62: 530-538. 
 
Kwok, S., Kellogg, D. E., McKinney, N., Spasic, D., Goda, L., Levenson, C., 
Sninsky, J. J. 1990. Effects of primer-template mismatches on the polymerase 
chain reaction: human immunodeficiency virus type 1 model studies.  Nucleic 
Acids Research 18: 999-1005. 
 
Lane, A. B., Soodyall, H., Arndt, M. E., Ratshikhopha, E., Jonker, C., Freeman, 
C., Young, L., Morar, B., Toffie, L. 2002. Genetic substructure in South African 
Bantu-speakers: evidence from autosomal DNA and Y-chromosome studies. 
American Journal of Physical Anthropology 119: 175-185. 
 
Lemey, P., Pybus, O. G, Wang, B., Saksena, N. K., Salemi, M., Vandamme, A. 
M. 2003. Tracing the origin and history of the HIV-2 epidemic. Proceedings of 
National Academy of Sciences 100: 6588-6592. 
 
Letvin, N., Barouch, D., Montefiori, D. 2002. Prospects for vaccine protection 
against HIV-1 infection and AIDS. Annual Review of Immunology 20: 73-99. 
 
88 
  
Lewotin, R.C. 1964. The interaction of selection and linkage. I. General 
considerations; heterotic models. Genetics 49: 49-67. 
 
Libert, F., Cochaux, P., Beckman, G., Samson, M., Aksenova, M., Cao, A., 
Czeizel, A., Claustres, M., de la Rúa, C., Ferrari, M., Ferrec, C., Glover, G., 
Grinde, B., Güran, S., Kucinskas, V., Lavinha, J., Mercier, B., Ogur, G., Peltonen, 
L., Rosatelli, C., Schwartz, M., Spitsyn, V., Timar, L., Beckman, L., Parmentier, 
M., Vassart, G. 1998. The ∆CCR5 mutation conferring protection against HIv-1 in 
Caucasian population has a single and recent origin in northeastern Europe. 
Human Molecular Genetics 7: 3399- 3406. 
 
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., Trono, D. 2003. Broad 
antiretroviral defense by human APOBEC3G through lethal editing of nascent 
reverse transcripts. Nature 424: 99-103. 
 
Mehle, A. J., Goncalves, M., Santa-Maria, M., McPike, M., Gabudza, D. 2004. 
Phosphorylation of a novel SOCS-box regulates the assembly of the HIV-1 Vif-
Cul5 complex that promotes APOBEC3G. Genes & Development 18: 2861-2866. 
 
Mendelman, L. V., Boosalis, M. S., Petruska, J. and Goodman, M. F. 1989. 
Nearest neighbor influences on DNA polymerase insertion fidelity. Journal of 
Biological Chemistry 264: 14415-14423. 
 
89 
  
Meyerson, N., and Sawyer, S., (2011).Two stepping through time: mammals and 
viruses. Trends in Microbiology 19: 286-294. 
 
Miller, J. H., Presnyak, V., Smith, H. C. 2007. The dimerization domain of HIV-1 
viral infectivity factor Vif is required to block virion incorporation of 
APOBEC3G. Retrovirology 4: 81-92. 
 
Mitchell, P. 2010.  Genetics and southern African prehistory: an archaeological 
view. Journal of Anthropological Sciences, 88:73–92. 
 
Mitchell, P., Whitelaw, G. 2005. The archaeology of southernmost Africa from c. 
2000 BP to early 1800s: A review of recent research. The Journal of African 
History 46: 209-241. 
 
Mountain, J. L., Risch, N. 2004. Assessing genetic contributions to phenotypic 
differences among “racial” and “ethnic” groups. Nature Genetics 36: S48-S53. 
 
Newton, C. R., Graham, A., Heptinstall, L., Powell, S. J., Summers, C., 
Kalsheker, N., Smith, J. C., Markham, A. F. 1989. Analysis of any point mutation 
in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids 
Research 17: 2503-2515. 
 
Novembre, J., Galvani, A. P., Slatkin, M., 2005. The geographic spread of the 
CCR5-∆32 HIV-Resistance allele. PLoS Biology 3: e339. 
90 
  
 
O’Brien, S.J., Nelson, G. W. 2004. Human genes that limit AIDS. Nature 
Genetics 36: 565-574. 
 
Okayama, H., Curiel, D. T., Brantly, M. L., Holmes, M. D., Crystal, R. G. 1989. 
Rapid, nonradioactive detection of mutations in the human genome by allele-
specific amplification. Journal of Laboratory and Clinical Medicine 114: 105-
113. 
 
Papathanasopoulos, M., Cilliers, T., Morris, L., Mokii, J., Dowling, W., Birx, D. 
L., McCutchan, F. E. 2002. Full length genome analysis of HIV-1 subtype c 
utilizing CXCR4 and intersubtype recombinants isolated in South Africa. AIDS 
Research and Human Retroviruses 18: 879-886. 
 
Pritchard, J.K., Rosenberg, N.A. 1999. Use of unlinked genetic markers to detect 
population stratification in association studies. American Journal of Human 
Genetics 65: 220-228. 
 
Ramdin, R., 2003.  Population variation in CEM 15, a gene involved in HIV 
replication.  BSc (Hons).  University of Witwatersrand. 
 
Reddy K., Winkler C.A, Werner L., Mlisana K., Abdool Karim SS, Ndung'u T. 
2010. APOBEC3G expression is dysregulated in primary HIV-1 infection and 
91 
  
polymorphic variants influence CD4+ T-cell counts and plasma viral load. AIDS 
24: 195-204. 
 
 
Reich, D. E., Cargill, M., Bolk, S., Ireland, J., Sabeti, P. C., Richter, D. J., Lavery,  
T., Kouyoumjian, R., Farhadian, S. F., Ward, R., Lander, E. S. 2001. Linkage 
disequilibrium in the human genome. Nature 411: 199-204. 
 
Ronaghi, M. 2003. Pyrosequencing for SNP genotyping. Methods in Molecular 
Biology 212: 189-195. 
 
Ronaghi, M., Uhlen, M., Nyren, P. 1998. A sequencing method based on real-time 
pyrophosphate. Science 281: 363-365. 
 
Sabeti, P. C., Walsh, E., Schaffner, S. F., Varilly, P., Fry, B., Hutcheson, H. B., 
Cullen, M., Mikkelsen, T. S., Roy, J., Patterson, N., Cooper, R., Reich, D., 
Altshuler, D., O'Brien, S., Lander, E. S. 2005. The case for selection at CCR5-
Delta32. PLoS Biology 3: e378. 
 
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., 
Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., 
Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth,  
R. J., Collman, R. G., Doms, R. W., Vassart, G., Parmentier, M. 1996. Resistance 
92 
  
to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 
chemokine receptor gene. Nature 383: 722-725. 
 
SantaLucia, J., Allawi, H. T., Seneviratne, P. A. 1996. Improved nearest-neighbor 
parameters for predicting DNA duplex stability. Biochemistry 35: 3555-3562. 
 
Sarkar, G., Cassady, J., Bottema, C., Sommer, S. 1990. Characterization of 
polymerase chain reaction amplification of specific alleles. Analytical 
Biochemistry 186: 64-68. 
 
Sawyer, S. L., Emerman, M., Malik, H. S. 2004. Ancient adaptive evolution of the 
primate antiviral DNA-Editing enzyme APOBEC3G. PLoS Biology 2: 1278-1285. 
 
Sheehy, A. M., Gaddis, N. C., Choi, J. D., Malim, M. H. 2002. Isolation of human 
gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. 
Nature 939: e1-5. 
 
Shifman, S., Kuypers, J., Kokoris, M., Yakir, B., Darvasi, A. 2003.  Linkage 
disequilibrium patterns of the human genome across populations. Hum. Mol. 
Genet. 12: 771-776. 
 
Sova, P., van Ranst, M., Gupta, P., Balachandran, R., Chao, W., Itescu, S., 
McKinley, G., Volsky, D. J. 1995. Conservation of an intact human 
93 
  
immunodeficiency virus type 1 vif gene in vitro and in vivo. Journal of Virology 
69: 2557-2564. 
 
Stephens, J. C., Reich, D. E., Goldstein, D. B. 1998. Dating the origin of the 
CCR5-∆32 AIDS-Resistance Allele by the coalescence of Haplotypes. American 
Journal of Human Genetics 62: 1507-1515. 
 
Stephens, M., Smith, N., Donnelly, P. 2001. A new statistical method for 
haplotype reconstruction based from population data. American Journal of Human 
Genetics 68: 978-989. 
 
Syvanen, A. 2001.Accessing genetic variation: genotyping single nucleotide 
polymorphisms. Nature Genetics 2: 930-940. 
 
Tindall, K. R., Kunkel, T. A. 1988. Fidelity of DNA synthesis by the Thermus 
aquaticus DNA polymerase. Biochemistry 27: 6008-6013. 
 
Tishkoff, S. A, Williams, S. 2002. Genetic analysis of African populations: 
human evolution and complex disease. Nature Review Genetics 3: 611- 621. 
 
Tishkoff, S. A., Kidd, K. K. 2004. Implications of biogeography of human 
populations for “race” and medicine. Nature Genetics 36: S21-S27. 
 
94 
  
Tishkoff, S. A., Verrelli, B.C. 2003. Patterns of human genetic diversity: 
implications for human evolutionary history and disease. Annual Review of 
Genomics and Human Genetics 4: 293-340. 
 
Tishkoff, S. A., Dietzsch, E., Speed, W., Pakstis, A. J., Kidd, J. R., Cheung, K., 
Bonné-Tamir, B., Santachiara-Benerecetti, A. S., Moral, P., Krings, M. 1996. 
Global patterns of linkage disequilibrium at the CD4 locus and modern human 
origins. Science 271: 1380-1387. 
 
Tishkoff, S. A., Pakstis, A. J., Stoneking, M., Kidd, J. R., Destro-Bisol, G. 2000. 
Short tandem-repeat polymorphism/Alu haplotype variation at the PLAT locus: 
implications for modern human origins. American Journal of Human Genetics 67: 
901-925. 
 
Turner, B., Summers, M. 1999. Structural biology of HIV. Journal of Molecular 
Biology 285: 1-32. 
 
Van Harmelen, J., Wood, R., Lambrick, M., Rybicki, E. P., Williamson, A. L, 
Williamson, C. 1997. An association between HIV-1 subtypes and mode of 
transmission in Cape Town, South Africa. AIDS 11: 81-87. 
 
Wall, J.D., Pritchard, J.K. 2003. Haplotype Blocks and Linkage disequilibrium in 
the Human Genome. Nature Review Genetics 4: 587-597 
 
95 
  
VanLiere, J. M., Rosenberg, N. A. 2008. Mathematical properties of the r2 
measure of linkage disequilibrium. Theoretical Population Biology 74: 130-137. 
 
Vartanian, J. P., Sommer, P., Wain-Hobson, S. 2003. Death and the retrovirus. 
Trends in Molecular Medicine 9: 409-413. 
 
 Vasina, J. 1995. An association between HIV-1 subtypes and mode of 
transmission in Cape Town, South Africa. Journal of African History 36: 173-
195. 
 
Vigilant, L., Stoneking, M., Harpending, H., Hawkes, K., Wilson, A. C. 1991 
African populations and the evolution of human mitochondrial DNA. Science 
253: 1503-1507. 
Watson, E., Bauer, K., Aman, R., Weiss, G., von Haeseler, A., Pääbo, S. 1996. 
mtDNA sequence diversity in Africa. American Journal of Human Genetics 59: 
437-444 . 
 
Wedekind, J., Dance, G., Sowden, M., Smith, H. 2003. Messenger RNA editing in 
mammals: new members of the APOBEC family seeking roles in the family 
business. Trends in Genetics 19: 207-216. 
 
96 
  
Williamson, C., Engelbrecht, S., Lambrick, M., van Rensburg, E., Wood, R., 
Bredell, W., Williamson, A. L. 1995. HIV-1 subtypes in different risk groups in 
South Africa. Lancet 346: 782. 
 
Wilson, A. C., Cann, R. L. 1992. The recent African genesis of humans. Scientific 
American 266: 68-73. 
 
Winkler, C. A., An, P., O’Brien, S., 2004. Patterns of ethnic diversity among the 
genes that influence AIDS. Human Molecular Genetics: R9-R19. 
 
Worobey, M., Gemmel, M., Teuwen, D. E., Haselkorn, T., Kunstman, K.,  Bunce,  
M., Muyembe, J. J., Kabongo, J. M., Kalengayi, R. M., Van Marck, E., Gilbert, 
M. T., Wolinsky, S. M. 2008. Direct evidence of extensive diversity of HIV-1 in 
Kinshasa by 1960. Nature 455: 661-665. 
 
 
Wu, D. Y., Ugozzoli, L., Pal, B. K., Wallace, R. B. 1989. Allele-specific 
enzymatic amplification of β-globin genomic DNA for diagnosis of sickle cell 
anemia. Proceedings of National Academy of Sciences 86: 2757-2760. 
 
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, K., Mao, P., Yu, X. F. 2003. Induction of 
APOBEC3G ubiquitination and degradation by an HIV-1Vif-Cul5-SCF complex. 
Science 302: 1056-1060. 
 
97 
  
Zhang, J., Webb, D. M. 2004. Rapid evolution of primate antiviral enzyme 
APOBEC3G. Human Molecular Genetics 13: 1785-17. 
 
Zhang, L., Saadatmand, J., Li, X., Guo, F., Niu, M., Jiang, J. 2008. Function 
analysis of sequences in human APOBEC3G involved in Vif-mediated 
degradation. Virology 370: 113-112. 
 
The Joint United Nations Programme on HIV/AIDS / World Health Organization. 
2007.  AIDS Epidemic Update. 
 
The Joint United Nations Programme on HIV/AIDS / World Health Organization. 
2005. AIDS Epidemic Update 
 
 
98 
  
Appendix I 
Table A.1: Raw genotyping data obtained using the allele-specific PCR at SNP -571 for the JHB samples, RFLP-PCR and 
Pyrosequencing™ assays 
 
Sample 
Description 
   
Sample 
# 
571-
ASA 
Sample 
# 
571-
ASA 
Sample 
# 
571-
ASA 
Sample 
# 
571-
ASA 
Sample 
# 
571-
ASA 
Sample 
# 
571-
ASA 
JHB 
104 CC 118 CC 147 CC 160 CC 177 GC 191 GC 
105 CC 120 CC 148 CC 161 CC 179 GC 192 GC 
106 CC 123 CC 149 CC 163 CC 180 GC 193 GC 
109 CC 124 CC 150 CC 164 CC 181 GC 194 GC 
110 CC 126 CC 151 CC 167 CC 182 GC 195 GC 
111 CC 127 CC 152 CC 168 CC 183 GC 197 GC 
112 CC 131 CC 153 CC 170 CC 184 GC 198 GC 
113 CC 138 CC 154 CC 171 CC 185 GC 199 GC 
114 CC 140 CC 155 CC 172 CC 187 GC 200 GC 
115 CC 141 CC 156 CC 173 CC 188 GC  
116 CC 143 CC 158 CC 175 GC 189 GC  
117 CC 146 CC 159 CC 176 GC 190 GC    
 
 
 LI 
  
Table A.2:  Raw genotyping data obtained using the allele-specific PCR at SNP -571 for the GP samples. 
Sample Description    Sample # 
571-
ASA Sample # 
571-
ASA Sample # 
571-
ASA Sample # 
571-
ASA Sample # 
571-
ASA Sample # 
571-
ASA 
GP 
201 GC 208 GC 214 GC 221 GC 228 GG 235 GG 
203 GC 209 GC 216 GC 222 GC 229 GG 236 GG 
204 GC 210 GC 217 GC 223 GG 230 GG 237 GG 
205 GC 211 GC 218 GC 224 GG 231 GG 239 GG 
206 GC 212 GC 219 GC 225 GG 232 GG 241 GG 
207 GC 213 GC 220 GC 227 GG 234 GG 243 GG 
   244 GG 
                       245 GG 
 
 
 
Table A.3: Raw genotyping data obtained using the allele-specific PCR at SNP -571 for the HIVNET samples. 
Sample Description 
   Sample 
# 571-ASA Sample # 571-ASA Sample # 571-ASA Sample # 571-ASA Sample # 571-ASA Sample # 571-ASA 
HIVNET 
521-160 GG 536-149 GG 541-193 GG 541-73 GG  615-31 GG 616-445 GG 
521-171 GG 536-173 GG 541-228 GG 541-98 GG 615-325 GG 616-453 GG 
521-298 GG  536-31 GG 541-234 GG 614-121 GG 615-332 GG 616-457 GG 
521-301 GG 541-115 GG 541-256 GG 615-107 GG 615-67 GG 616-472 GG 
521-327 GG 541-131 GG 541-353 GG  615-11 GG 615-78 GG 616-486 GG 
521-343 GG 541-144 GG 541-36 GG 615-136 GG 615-80 GG 616-499 GG 
536-015 GG 541-178 GG 541-49 GG  615-15 GG 615-93 GG 616-503 GG 
536-107 GG 541-180 GG 541-62 GG  615-26 GG 616-17 GG  616-90 GG 
                      615-366 GG 
 
 LII 
  
 
Table A.4:  Raw genotyping data obtained using the RFLP-PCR at SNP -571 and Pyrosequencing at SNP H186R for the JHB samples. 
 
Sample Description Sample 
H186R-
PYRO 
571- 
RFLP Sample 
H186R-
PYRO 
571- 
RFLP Sample 
H186R-
PYRO 
571- 
RFLP Sample 
H186R-
PYRO 
571- 
RFLP 
JHB 
101 CT GC 113 TT GG 126 CC GG 142 CT GG 
105 CT GG 114 TT CC 127 TT GC   
106 CT GC 118 CC GC 131 CT GG   
  111 CC GG 119 CC GG 141 CT GC       
 
 
 
 
Table A.5:  Raw genotyping data obtained using the RFLP-PCR at SNP -571 and Pyrosequencing at SNP H186R for the GP samples. 
 
Sample Description Sample 
H186R-
PYRO 
571- 
RFLP Sample 
H186R-
PYRO 
571- 
RFLP Sample 
H186R-
PYRO 
571- 
RFLP Sample 
H186R-
PYRO 
571- 
RFLP 
GP 
206 TT GG 217 CT GG 230 CT GG 240 TT GG 
208 TT GG 221 CT GG 231 CT GG 241 TT GG 
209 CT GG 222 CT GG 232 CT GG 242 TT GC 
210 CT GG 223 TT GG 233 CC GG 243 CC GC 
212 TT GG 224 TT GG 234 CT GG 245 CT GG 
213 CT GG 226 CT GG 235 TT GG   
214 CT GG 227 CT GC 237 CT GG   
  215 CT GG 228 CT GG 238 TT GG   
  216 CT GG 229 CT GG 239 CC GG       
 
 
 
 LIII 
  
Table A.6:  Raw genotyping data obtained using the RFLP-PCR at SNP -571 and Pyrosequencing at SNP H186R for the HJ samples. 
 
Sample Description Sample 
H186R-
PYRO 
571- 
RFLP Sample 
H186R-
PYRO 
571- 
RFLP Sample 
H186R-
PYRO 571- RFLP Sample 
H186R-
PYRO 
571- 
RFLP 
HJ 
300 CT GG 322 CT GG 344 CT GC 375 CT GC 
301 CC GG 323 CT GG 346 CT GG 376 CT GC 
302 CC GG 324 CT GC 347 TT GC 377 CT GC 
303 CC GC 325 CT GC 348 CT GC 378 CT GG 
304 CC GC 326 CT GC 349 TT CC 381 CT GG 
305 CC GC 327 CC GC 357 CT GG 383 CT GC 
306 CT GG 328 CT GC 358 CT GG 384 CT GG 
307 CC GG 329 CT GC 356 CT GC 385 CT GG 
308 CC GG 330 CT GC 379 CT GG 386 CT GG 
309 CT GG 331 CT GC 361 TT GG 387 TT GG 
310 CT GG 332 CC GC 362 CT GG 390 CT GG 
311 CT GG 333 CT GC 363 CT GG 391 CC GG 
312 CT GC 334 CT GC 365 CT GG 392 CT GG 
313 CT GG 335 CC GC 366 CT GG 393 TT GG 
314 TT GC 336 CT GC 367 CT GG 394 CT GG 
315 TT GG 337 CT GC 368 CT GG 395 CT GG 
316 CT GG 338 CT GC 369 CC GG 396 CC GG 
317 CC GG 339 CT GG 370 CC GG 397 CC GG 
   318 CT GG 340 TT GG 371 TT GG 398 CT GG 
   319 CT GG 341 CT GC 372 CT GC 399 TT GG 
   320 CT GG 342 CC GG 373 CT GC 400 CT GG 
   321 CT GG 343 TT GG 374 TT GC 401 CT GG 
                        402 CT GG 
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Figure B.1: Ethics clearance certificate obtained from the Human Research Ethics 
Committee at the University of the Witwatersrand 
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